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Full-thickness skin defects after burns, infection, trauma or tumor resection are a frequent 
challenge in reconstructive surgery. Most defects can be treated by means of autologous 
split-thickness skin grafts (STSG), which are the gold standard for the reconstruction of 
extensive skin loss. However, wounds above bradytrophic structures, such as tendons and 
bones, commonly do not exhibit a sufficient vascularization capacity to be covered with 
STSG alone. Moreover, STSG coverage is prone to restrictive scarring with subsequent 
functional and esthetic restrictions. Consequently, off-the-shelf dermal skin substitutes have 
been introduced for the restoration of the dermal layer. For instance, the clinically established 
Integra is characterized by an engineered collagen-glycosaminoglycan matrix, which 
provides guidance for infiltrating host cells with subsequent formation of a microvascular 
network. Stable revascularization of the implant requires ~ 21 days, and only after this 
period, STSG coverage can be performed. Importantly, this delayed vascularization kinetics 
is associated with high costs, two surgeries and an increased risk of infection with implant 
loosening. One approach to overcome this problem is prevascularization, i.e. the induction of 
a functional microvascular network within the matrix before implantation into a host organism. 
In the present thesis, adipose tissue-derived microvascular fragments (ad-MVF) are 
introduced as a novel prevascularization strategy for dermal skin substitutes. In contrast to 
adipose tissue-derived single cell isolates, ad-MVF consist of intact arteriolar, capillary and 
venular fragments and only have to reconnect to each other and the host microvasculature 
for the formation of a functional microvascular network. This work is based on three original 
articles investigating the isolation process of ad-MVF, their in vitro characterization and the in 
vivo application of ad-MVF-prevascularized Integra in two murine wound models. 
In the first study of this thesis, a standardized protocol for the enzymatic isolation of ad-
MVF from epididymal fat pads of mice is reported. The fat pads of transgenic green 
fluorescence protein (GFP)+ C57BL/6 mice were harvested for the isolation of ad-MVF, which 
were subsequently characterized by means of microscopy, histology, immunohistochemistry 
and flow cytometry. The total time required for the isolation process was ~ 120 min. It was 
possible to isolate ~ 40,000 ad-MVF per mL adipose tissue. Individual fragments exhibited a 
mean length of 42 ± 1 µm. Moreover, they were characterized by a typical microvessel 
morphology with hierarchical vessel segments as indicated by immunohistochemical 
analyses. Flow cytometry revealed that ad-MVF contain 26 ± 2 % CD31+ endothelial cells, 17 
± 2 % α-smooth muscle actin (SMA)+ perivascular cells and 9 ± 1 % cells positive for the 
mesenchymal stem cell marker CD117. Pilot experiments with ad-MVF-seeding onto Integra 
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indicated that the fragments were mainly localized on the implant's surface and only a few 
capillary vessel segments could be detected within its pores immediately after the seeding 
process. 
In the second study of this thesis, Integra seeded with GFP+ ad-MVF was investigated after 
implantation into full-thickness skin defects in a modified dorsal skinfold chamber model of 
wild-type C57BL/6 mice. Non-seeded implants served as controls. The in vivo experiments 
consisted of a 14 days-observation period with repetitive intravital fluorescence microscopy 
and stereomicroscopy for the assessment of the implants' vascularization and 
epithelialization. After 14 days, histological and immunohistochemical analyses of 
vascularization, lymphangiogenesis, epithelialization and collagen content were performed. 
The GFP+/GFP- crossover approach allowed the identification of ad-MVF-derived blood and 
lymphatic vessels in the implants as well as in the surrounding skin. The ad-MVF rapidly 
reassembled into microvascular networks within the implants and inosculated to the host 
microvasculature between day 3 and 6 after transplantation. Accordingly, the vascularization 
of the implants was markedly accelerated, as indicated by a significantly higher microvessel 
density when compared to controls. Moreover, dense lymphatic networks originating from the 
GFP+ ad-MVF developed within the implants. The GFP+ blood and lymphatic vessels even 
invaded the surrounding skin. Finally, enhanced vascularization and lymphangiogenesis 
resulted in an increased implant integration and epithelialization.  
 
In the third study of this thesis, ad-MVF-based prevascularization of Integra was analyzed 
in a novel animal model. In a first set of experiments, Integra seeded with GFP+ ad-MVF was 
implanted into full-thickness skin defects on the skull of CD1 nu/nu mice for 21 days. Non-
seeded implants served as controls. The implants were assessed in situ by means of photo-
acoustic imaging. At the end of the in vivo experiments, vascularization, lymphangiogenesis 
as well as incorporation of the implants were analyzed using trans-illumination 
stereomicroscopy, histology and immunohistochemistry. In a second set of experiments, 
early autologous STSG coverage was performed 10 days after implantation of 
prevascularized and non-seeded Integra. The survival rate of STSG was assessed by 
planimetry and 5 days after STSG transplantation, the implants and the STSG were excised 
for histological and immunohistochemical analyses. After 21 days, the density of 
microvascular and lymphatic networks was markedly higher in prevascularized matrices 
when compared to controls. This was associated with an improved integration of the 
implants. Moreover, prevascularization with ad-MVF allowed successful STSG coverage 
already at day 10. In contrast, skin grafting of non-seeded controls resulted in STSG 
necrosis. 
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In summary, ad-MVF-seeding represents a novel and promising prevascularization strategy 
for the dermal skin substitute Integra. Murine ad-MVF enhance the vascularization and 
lymphangiogenesis of Integra and also result in a faster integration and epithelialization of 
the implant. Key advantages of ad-MVF prevascularization are the short isolation time and 
the intact microvascular characteristics, which are prerequisites for an intraoperative one-
staged application. However, from a translational perspective, it has to be proven that ad-
MVF harvested from subcutaneous adipose tissue of humans exhibit an equally high 
vascularization capacity compared with murine ad-MVF. If this holds true, ad-MVF may soon 
be taken from bench to bedside.  
 





Ausgedehnte Hautdefekte sind ein häufiges Problem in der rekonstruktiven Chirurgie. Der 
Goldstandard für die Behandlung der meisten Hautdefekte ist die autologe 
Spalthauttransplantation. Gewisse Defekte sind aber einer Spalthautdeckung nicht 
zugänglich. So sind die dünnen Hauttransplantate nicht geeignet für die Deckung von 
Wunden mit schlecht vaskularisiertem Wundgrund, zum Beispiel bei freiliegenden Sehnen 
oder Knochen. Ein weiteres relevantes Problem ist die Ausbildung von funktionellen und 
kosmetisch invalidisierenden Narbenkontrakturen. Biosynthetische dermale Ersatzmatrizen, 
wie das klinisch oft verwendete Integra, stellen eine Möglichkeit dar, diese Probleme zu 
umgehen. Integra besteht aus einer Kollagen-Glycosaminoglycan Matrix, in welche ein 
mikrovaskuläres Gefäßnetzwerk aus dem umgebenden Empfängergewebe vor einer 
Spalthautdeckung einsprossen muss. Dieser Prozess benötigt ungefähr 3 Wochen. Danach 
kann die Matrix mit Spalthaut gedeckt werden. Diese verzögerte Vaskularisierung resultiert in 
zwei operativen Eingriffen, in einem erhöhten Infektionsrisiko mit möglichem Implantatverlust 
sowie in hohen Kosten. Ein möglicher Lösungsansatz für dieses Problem basiert auf dem 
Prinzip der Prävaskularisierung. Der Begriff stammt aus dem Tissue Engineering und 
bedeutet die Induktion eines funktionellen Gefäßnetzwerkes in einem Gewebekonstrukt vor 
Implantation in einen Empfängerorganismus. In der vorliegenden Arbeit werden aus 
Fettgewebe isolierte mikrovaskuläre Fragmente (ad-MVF) als vielversprechende 
Prävaskularisierungs-Strategie für dermale Matrizen eingeführt. ad-MVF bestehen aus 
intakten arteriolären, kapillären und venulären Gefäßfragmenten, welche sich nach 
Implantation in einen Empfängerorganismus lediglich wieder zu einem mikrovaskulären 
Netzwerk verbinden müssen. Dies unterscheidet sie wesentlich von Einzelzell-basierten 
Isolaten aus Fettgewebe, wie zum Beispiel der stromal vascular fraction, die ebenfalls häufig 
für die Prävaskularisierung von Implantaten verwendet wird. Diese Arbeit beruht auf drei 
Originalarbeiten, welche die Isolation von ad-MVF, deren in vitro Charakterisierung sowie die 
in vivo Anwendung von mit ad-MVF prävaskularisiertem Integra in zwei Mausmodellen 
beschreiben. 
In der ersten Studie wird ein ein standardisiertes Protokoll für die Isolation von ad-MVF aus 
epididymalem Fettgewebe von Mäusen beschrieben. Hierfür wurden ad-MVF von 
transgenen, green fluorescent protein (GFP)+ C57BL/6 Mäusen enzymatisch isoliert und 
mittels Mikroskopie, Histologie, Immunhistochemie und Durchflusszytometrie charakterisiert. 
Die Gesamtzeit für die Isolation betrug  ~ 120 Minuten. Es konnten ~ 40,000 ad-MVF pro ml 
Fettgewebe gewonnen werden. Die einzelnen Fragmente wiesen eine durchschnittliche 
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Länge von 42 ± 1 µm und eine typische mikrovaskuläre Morphologie auf. 
Durchflusszytometrische Analysen zeigten, dass ad-MVF 26 ± 2 % CD31+ Endothelzellen, 17 
± 2 % α-smooth muscle actin (SMA)+ perivaskuläre Zellen und 9 ± 1 % mesenchymale 
Stammzellen charakterisierende CD117+ Zellen enthalten. In Pilotversuchen wurden ad-MVF 
auf Integra gesiedelt. Auf diese Weise konnte histologisch gezeigt werden, dass der 
überwiegende Anteil der ad-MVF auf der Oberfläche des Implantates lokalisiert war und nur 
wenige kapilläre ad-MVF in die Poren von Integra eindringen konnten.  
In der zweiten Studie wurde prävaskularisiertes Integra in Hautdefekten in einer 
modifizierten Rückenhautkammer an C57BL/6 Mäusen untersucht. Hierfür wurden die 
Implantate mit GFP+ ad-MVF besiedelt. So konnte nach Implantation in GFP- C57BL/6 Tiere 
zwischen GFP- Empfängergefäßen und GFP+ Gefäßen, die sich aus den ad-MVF 
entwickelten, unterschieden werden. Die Kontrollgruppe bestand aus unbesiedelten 
Implantaten. Während eines 14-tägigen in vivo Versuches wurden die Vaskularisierung und 
Epithelialiserung der Implantate mittels intravitaler Fluoreszenzmikroskopie sowie 
stereomikroskopischer Planimetrie erfasst. Nach 14 Tagen wurden die Implantate für die 
histologische und immunhistochemische Analyse der Vaskularisierung, Lymphangiogenese 
und Epithelialisierung sowie für die Quantifizierung des Kollagengehaltes entnommen. 
Interessanterweise bildeten die ad-MVF in kurzer Zeit innerhalb des Integra ein funktionelles 
Gefäßnetzwerk aus, welches über Inoskulation nach 3 - 6 Tagen Anschluss an die Gefäße 
des Empfängergewebes fand. Entsprechend konnte in den prävaskularisierten Implantaten 
eine deutlich verbesserte Vaskularisierung mit signifikant höherer mikrovaskulärer Dichte im 
Vergleich zu den nicht-besiedelten Implantaten der Kontrollgruppe nachgewiesen werden. 
Weiterhin wiesen die ad-MVF-besiedelten Implantate auch ein deutlich dichteres 
Lymphgefäßnetzwerk auf. GFP+ Blut- und Lymphgefäße waren nicht nur in den Implantaten, 
sondern auch im umliegenden Empfängergewebe nachweisbar. Die verbesserte 
Vaskularisierung und Lymphangiogenese führten letztlich zu einer verstärkten Integration 
und Epithelialisierung der dermalen Matrizen. 
In der dritten Studie wurde ad-MVF-prävaskularisiertes Integra hinsichtlich einer vorzeitigen 
Spalthautdeckung in einem neuen Mausmodell untersucht. Die Hypothese dieser Studie 
lautete, dass durch die Prävaskularisierung eine Spalthautdeckung früher möglich ist. Hierfür 
wurden in einem ersten Studienabschnitt besiedeltes und unbesiedeltes Integra in einen 
Hautdefekt auf dem Schädel von CD1 nu/nu Mäusen über 21 Tage implantiert. Während des 
in vivo Versuches wurde die Vaskularisierung der Implantate mittels Photoakustik analysiert. 
Nach Entnahme der Implantate wurden Vaskularisierung, Lymphangiogenese sowie die 
Gewebeintegration mittels Transilluminations-Stereomikroskopie, Histologie und 
Immunhistochemie erfasst. In einem zweiten Studienabschnitt wurden prävaskularisiertes 
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und nicht-prävaskularisiertes Integra 10 Tage nach Implantation mit autologen 
Spalthauttransplantaten gedeckt und für 5 weitere Tage mittels stereomikroskopischer 
Planimetrie untersucht. So konnte die prozentuale Überlebensrate der Transplantate 
objektiviert werden. Die Präparate wurden anschließend histologisch und 
immunhistochemisch ausgewertet. Nach 21 Tagen wiesen die prävaskularisierten Implantate 
analog zur zweiten Studie ein signifikant dichteres Blut- und Lymphgefäßnetzwerk im 
Vergleich zu den nicht-besiedelten Implantaten der Kontrollgruppe auf. Dies ging mit einer 
verbesserten Integration in das Gewebe einher. Die vorzeitige Spalthauttransplantation war 
nur auf den prävaskularisierten Implantaten möglich, wohingegen die Hauttransplantate auf 
den unbesiedelten Implantaten der Kontrollgruppe nekrotisch wurden. 
Abschließend kann festgehalten werden, dass murine ad-MVF eine vielversprechende 
Prävaskularisierungs-Strategie für dermale Ersatzmatrizen darstellen. Sie verbessern nicht 
nur die Ausbildung von Blut- und Lymphgefäßen innerhalb von Integra, sondern sind auch 
mit einer schnelleren Integration und Epithelialisierung der Implantate assoziiert. Von grosser 
Bedeutung sind die kurze Isolationszeit sowie die erhaltene mikrovaskuläre Morphologie der 
ad-MVF. Diese Punkte stellen eine conditio sine qua non für eine einzeitige intraoperative 
Anwendung dar. Aus der Perspektive des Klinikers müssen zukünftige Versuche zeigen, ob 
ad-MVF aus humanem Fettgewebe ein vergleichbar hohes Vaskularisierungspotential 
aufweisen. Dann wären ad-MVF-prävaskularisierte dermale Ersatzmatrizen in der Tat ein 
interessanter Therapieansatz für therapie-refraktäre chronische Wunden.  
 





The skin is the largest organ of the human body and provides a first line of defense against 
microbial pathogens and physical or chemical insults [NESTLE et al., 2009]. Moreover, it is 
critically involved in the regulation of body temperature and tissue fluid homeostasis [CUENI 
and DETMAR, 2006; ROMANOFSKY, 2014]. From a morphological point of view, the skin 
consists of two main structural compartments: The epidermis and the dermis (Figure 1). The 
epidermal layer is a continuously self-renewing epithelium protecting the skin from hazardous 
environmental threats [BARONI et al., 2012]. An intimate cooperation between epithelial cells, 
growth factors, chemokines and inflammatory cells is the prerequisite for the regeneration of 
wounded skin [TOULON et al., 2009; HAVRAN and JAMESON, 2010]. In contrast, the dermis is 
characterized by a papillary layer and a 
lower reticular layer. The extracellular matrix 
of these layers is built on collagen and 
elastin fibers and the main cellular 
component are fibroblasts, which 
continuously produce collagen and 
proteoglycan matrix [KAMEL et al., 2013]. 
Furthermore, the dermis contains a dense 
microvascular and lymphatic plexus 
nourishing and draining the avascular 
epidermis. In addition, sweat and sebaceous 
glands as well as hair follicles are part of the 
dermal compartment. Finally, the loose 
connective tissue and subcutaneous fat of the 
hypodermis is involved in mechanical shock 
protection and is active in energy metabolism 
and storage [BARONI et al., 2012]. Together, 
the dermis and hypodermis are responsible 
for mechanical support and protection 
[HUSSAIN et al., 2013] . Extensive full-thick-
ness skin injury may lead to life-threatening systemic complications due to massive fluid loss, 
decrease of body temperature or infection. The most common etiologies for significant skin 
loss include burns, necrotizing infections, trauma and tumor resection [AKHTAR et al., 2006; 
PHAM et al., 2007; TUFARO et al., 2007; FRUEH et al., 2016]. Particularly burn injuries 
affecting ~ 20 % or more of the total body surface can result in a fatal systemic response, 
Figure 1. The structure of human skin. This 
illustration shows the two main layers of skin: The 
epidermis and the lower, much thicker, dermis. The 
epidermal barrier is relatively thin (0.1 – 0.2 mm) 
and is secured to the underlying dermis by a 
specialized basement membrane. The dermis 
varies in thickness and is well vascularized with an 
arterial (empty arrowhead), venous (black 
arrowhead) and lymphatic (asterisks) network. 
Reproduced with permission from Frueh et al., 
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known as burn shock [ROWAN et al., 2015]. Beside these injuries, chronic wounds are a 
socio-economically highly relevant problem. In the United States of America, approximately 
6.5 million patients suffer from chronic wounds and the burden is constantly growing due to 
an aging population and a rising incidence of diabetes, obesity and vasculopathies [SEN et 
al., 2009]. For both acute and chronic wounds, a rapid and stable reconstruction is crucial to 
prevent potentially fatal complications. In clinical practice, many skin defects can be 
successfully treated using split-thickness skin grafts (STSG).  
 
The principle of autologous skin grafting goes back to REVERDIN [1869] and has been the 
gold standard in the treatment of extensive skin defects in the last 150 years. STSG are easy 
to harvest and exhibit a low donor-site morbidity. They contain the epidermis and a variably 
thick part of the dermis and are revascularized within 72 hours after transplantation [FRUEH et 
al., 2018a]. Graft revascularization is characterized by a complex combination of 
angiogenesis, vasculogenesis and inosculation. Briefly, the majority of a graft's 
microvasculature regresses and is replaced by ingrowing microvessels from the wound bed 
and after inosculation within 48 - 72 hours, the graft is re-oxygenated [CAPLA et al., 2006; 
LINDENBLATT et al., 2010]. This process requires an intact microvascular network at the 
recipient site. However, chronic wounds and skin defects above bradytrophic structures, 
such as tendons and bones, commonly do not exhibit a sufficient vascularization capacity to 
be covered with STSG alone. Moreover, in case of full-thickness skin loss including the 
hypodermal layer, STSG coverage is prone to restrictive scarring with subsequent functional 
and esthetic restrictions [SHEVCHENKO et al., 2010]. Finally, skin loss involving the majority of 
the body's surface precludes STSG harvesting. These limitations are the clinical background 
for the discipline of skin tissue engineering and led to the development of a multitude of 
artificial skin substitutes. 
 
Tissue engineering is a rapidly expanding field of science. In 1987 the National Science 
Foundation defined it as "an interdisciplinary field that applies the principles of engineering 
and the life sciences towards the development of biological substitutes that restore, maintain 
or improve tissue function" [LANGER and VACANTI, 1993]. Importantly, vascularization is the 
key challenge in tissue engineering and the re-establishment of a functional macro- and 
microvascular network is the major hurdle for clinical translation of engineered tissues or 
organs [LASCHKE et al., 2006; NOVOSEL et al., 2011]. However, epidermal skin substitutes 
have been among the first for human application because they do not require an extensive 
internal vasculature [GALLICO et al., 1984; MACNEIL, 2007|. In contrast, skin substitutes that 
are thicker than 100-200 µm need a vascular system because every cell in a tissue needs to 
be close enough to capillaries to absorb oxygen and nutrients [KHADEMHOSSEINI et al., 2009]. 
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Accordingly, insufficient vascularization may result in infection, loosening and partial or 
complete necrosis of an implanted skin substitute [HENDRICKX et al., 2011]. Hence, the 
engineering of complex multi-layer skin substitutes is challenging and crucially depends on 
the integration of a functional microvascular network.  
 
Several strategies have been developed to engineer a functional microvascular network 
within artificial skin. They can be classified into angiogenesis approaches and 
prevascularization approaches [LASCHKE and MENGER, 2016a; FRUEH et al., 2017a]. 
Vascularization strategies based on angiogenesis try to stimulate the ingrowth of blood 
vessels into skin substitutes. This can be achieved by modification of the structure 
[SCHNEIDER et al., 2009], by surface activation with plasma treatment [RING et al., 2010], by 
combination of different biomaterials [WANG et al., 2013; ZHAO et al., 2015], or by 
incorporation of angiogenic growth factors, such as vascular endothelial growth factor 
(VEGF) or platelet-derived growth factor (PDGF) [MARGOLIS et al., 2004; RECKHENRICH et al., 
2011]. However, angiogenic approaches are clearly limited by a slow average growth rate of 
newly developing microvessels of only ~ 5 µm/h [UTZINGER et al., 2015], which precludes the 
vascularization of large skin substitutes by angiogenesis alone. To overcome this problem, 
the concept of prevascularization has emerged in the last decade. It aims at the generation 
of a preformed microvascular network inside engineered tissues prior to their implantation 
with subsequent connection to the recipient's microvasculature through inosculation 
[LASCHKE et al., 2009; LASCHKE and MENGER, 2016a]. Hence, in contrast to mainly 
angiogenesis-dependent vascularization, prevascularization should significantly shorten the 
hypoxic time period after implantation, during which skin substitutes may undergo critical 
ischemic damage. In skin tissue engineering, one promising prevascularization strategy is 
based on the cultivation of artificial skin grafts with vessel-forming cells. For instance, 
MARINO et al. [2014] introduced dermo-epidermal skin grafts engineered from human 
keratinocytes, human dermal fibroblasts and human dermal microvascular endothelial cells 
(HDMEC). The co-culture of these cells in fibrin hydrogels yields bi-layer skin substitutes with 
a functional microvascular network. Even though convincing in the preclinical setting, this 
approach has not yet been implemented into clinical routine because it includes in vitro 
incubation over weeks and relevant cell manipulation. In theory, the ideal prevascularization 
strategy for a future clinical translation should i) minimize in vitro steps, ii) involve as few cell 
manipulation as possible, iii) be minimally invasive for the patient, and iv) be suitable for a 
one-step operative procedure. The enrichment of skin substitutes with adipose tissue-derived 
microvascular fragments (ad-MVF) basically complies with these requirements. In the 
present thesis the suitability of ad-MVF as a novel prevascularization approach in skin tissue 
engineering was investigated [FRUEH et al., 2017b, 2017c and 2018b].  
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Historically, ad-MVF were isolated for the first time from the epididymal fat pads of rats 
[WAGNER et al., 1972; WAGNER and MATTHEWS, 1975]. They initially served for the isolation 
of capillary endothelium as well as for in vitro sprouting assays in angiogenesis research. 
Moreover, ad-MVF-seeded collagen gels were investigated for in vivo modeling of sprouting 
angiogenesis, vascularization and vascular remodeling [SHEPHERD et al., 2004]. ad-MVF 
represent a randomized mixture of arteriolar, capillary and venular vessel segments with all 
their morphological characteristics [HOYING et al., 1996; LASCHKE and MENGER, 2015]. 
Importantly, these segments still contain a lumen, an intact endothelium and vessel-
stabilizing perivascular cells. Therefore, they only have to interconnect with each other and 
with the surrounding microvasculature to form a functional, blood-perfused microvascular 
network [LASCHKE et al., 2012]. This complex process is characterized by three 
morphologically defined vascular phenotypes: i) The formation of angiogenic sprouts, which 
form immature vessel segments for subsequent inosculation to the surrounding 
microvasculature, ii) vascular remodeling of the new microvasculature and finally, iii) vascular 
maturation resulting in a hierarchical microvascular network [NUNES et al., 2010]. The 
remarkable vascularization capacity of ad-MVF can be explained by experimental findings: 
Under culture conditions, they release growth factors, such as VEGF or basic fibroblast 
growth factor (bFGF), indicating a pro-angiogenic paracrine activity  [LASCHKE et al., 2012; 
PILIA et al., 2014]. Moreover, ad-MVF contain Sca-1+/VEGF receptor-2+ endothelial 
progenitor cells as well as mesenchymal stem cells, which further increase their potency as 
vascular building units [LASCHKE et al., 2012; MCDANIEL et al., 2014]. 
 
The suitability of ad-MVF as vascularization units in regenerative medicine was first 
investigated by NAKANO et al. [1998], who found an improved survival of random pattern skin 
flaps on the back of rats after injecting the distal flap area with ad-MVF. In a subsequent 
study, they reported ad-MVF inosculation and survival after injection into superficial rat 
myocardium [NAKANO et al., 1999]. Further evidence that ad-MVF exhibit a high regenerative 
potential was reported by SHEPHERD et al. [2007], who analyzed the role of ad-MVF in a 
murine model of acute myocardial infarction. Of interest, epicardial transplantation of ad-
MVF-prevascularized collagen patches was associated with a smaller infarct size and an 
improved left ventricular function when compared to control animals, which were treated with 
non-prevascularized patches. In line with these findings, ad-MVF-derived microvascular 
networks also promoted the survival of transplanted pancreatic islets [HISCOX et al., 2008] 
and skeletal muscle regeneration [PILIA et al., 2014] in rodents. The idea of using ad-MVF as 
natural vascularization units for tissue engineering scaffolds was introduced by LASCHKE et 
al. who established a dynamic seeding procedure for porous polyurethane scaffolds 
[LASCHKE et al. 2012; LASCHKE et al., 2014]. For that purpose, they isolated GFP+ ad-MVF 
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from transgenic donor mice. After the seeding process, the scaffolds were implanted into 
dorsal skinfold chambers of wild-type mice for subsequent analyses by means of intravital 
fluorescence microscopy, histology and immunohistochemistry. The experimental GFP+/GFP- 
crossover approach revealed that > 90 % of the microvessels within the scaffolds were 
GFP+, hence originated from the transplanted ad-MVF. In summary, the scaffolds 
vascularized primarily through external inosculation, i.e. the interconnection of outgrowing 
GFP+ microvessels with the host microvasculature [LASCHKE et al., 2012]. Based on the 
findings of these studies, it was hypothesized in the present thesis that ad-MVF may also be 
promising vascularization units for skin tissue engineering.  
 
For the experiments of the present work the dermal skin substitute Integra (Integra Life 
Sciences, Plainsboro, NJ, USA) was chosen as scaffold for ad-MVF seeding. There are two 
FDA-approved and clinically established implants available: 1) Integra® Dermal Regeneration 
Template (bilayer Integra), which is made of a porous matrix of fibers of cross-linked bovine 
tendon collagen and shark chondroitin-6-sulfate [BURKE et al., 1981]. The artificial dermis is 
manufactured with a defined degradation rate and a controlled porosity, exhibiting pore sizes 
of 20 – 125 µm. In contrast, the superficial layer consists of a thin polysiloxane (silicone) 
layer to prevent moisture loss from the wound. In clinical practice, bilayer Integra is used to 
cover wounds with impaired vascularization, such as exposed bones or tendons, or for 
critically ill patients who are not eligible for reconstructive flap surgery. In a first step, the 
wound is debrided and covered with bilayer Integra. The dermal skin substitute should be 
well secured to the underlying wound to allow revascularization by ingrowing host 
microvessels, which takes approximately 21 days. After this interval, the silicone layer is 
removed and the revascularized neo-dermis can be covered with a STSG. 2) In contrast, 
Integra® Dermal Regeneration Template Single Layer (single layer Integra) only consists of a 
thin porous matrix without silicone layer. It is used in a one-staged procedure with immediate 
STSG coverage. However, its application is limited to smaller defects and, therefore, is less 
frequently used in clinical skin reconstruction.  
 
The main drawback of both Integra implants is the long time period until a stable 
microvascular network is established. This delay of vascularization bears the risk of wound 
infection and is associated with extended patient hospitalization and the perioperative risk of 
two surgeries [FRUEH et al., 2017b]. Accordingly, numerous approaches have been 
suggested to enhance the slow vascularization kinetics of Integra [FRUEH et al., 2017a]. 
Prevascularization based on adipose tissue-derived angiogenic cells is particularly appealing 
from a translational perspective, because human adipose tissue is commonly available in 
abundant amounts, expendable and easily accessible by means of liposuction. In the 
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preclinical setting, different adipose tissue-based cellular isolates have been shown to 
enhance the vascularization of Integra. For instance, the stromal vascular fraction (SVF) is 
an uncultured heterogeneous cell population mainly composed of endothelial cells, immune 
cells, pericytes and hematopoietic stem cells [KLAR et al., 2017]. The implantation of SVF-
loaded Integra in porcine full-thickness burn wounds resulted in a higher blood vessel density 
and maturation compared with non-loaded controls [FOUBERT et al., 2015]. Furthermore, 
adipose tissue-derived mesenchymal stem cells (ADSC) markedly enhanced implant 
vascularization and remodeling [MERUANE et al., 2012; CHERUBINO et al., 2016]. The 
prevascularization of Integra with ad-MVF may exhibit an even faster vascularization when 
compared to dermal substitutes enriched with single cell-isolates, such as the SVF or ADSC. 
To test the suitability of ad-MVF for this purpose, three experimental studies were performed 
between 2015 and 2018 for the present thesis. For all in vitro and in vivo experiments, male 
transgenic C57BL/6-Tg(CAG-EGFP)1Osb/J mice were used as adipose tissue donors for the 
isolation of ad-MVF. This transgenic mouse line is transfected with enhanced GFP cDNA 
under the transcriptional control of a chicken β-actin promoter and cytomegalovirus 
enhancer. Accordingly, all tissues of these animals except red blood cells and hair appear 
green under blue light excitation [OKABE et al., 1997], enabling a reliable identification of ad-
MVF-derived microvascular networks after transplantation into GFP- C57BL/6 wild-type mice.  
 
In the first study of this thesis, a standardized protocol for the enzymatic isolation of ad-
MVF from epididymal fat pads of mice is reported [FRUEH et al., 2017c]. The fat pads of GFP+ 
C57BL/6 mice were harvested and the amount of adipose tissue was quantified. 
Subsequently, ad-MVF were isolated by means of mechanical mincing and enzymatic 
digestion with collagenase for approximately 10 minutes. The time required for adipose 
harvesting and for the entire isolation process was recorded. Thereafter, the amount of 
isolated ad-MVF per mL adipose tissue as well as the mean length of individual fragments 
was evaluated by means of microscopy and histology. Furthermore, immunohistochemical 
analyses were performed to assess the microvascular morphology of isolated ad-MVF. 
Finally, the cellular composition of ad-MVF was characterized by means of flow cytometry. 
For this purpose, they were further digested in cell detachment solution into single cells. In 
additional pilot experiments, freshly isolated ad-MVF were seeded onto single layer Integra 
with subsequent histological and immunohistochemical analyses of the prevascularized 
implants. 
 
After the first promising in vitro experiments, the in vivo performance of ad-MVF-
prevascularized single layer Integra was evaluated in the second study using a modified 
dorsal skinfold chamber model [FRUEH et al., 2017b]. This versatile animal model is suitable 
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for non-invasive microcirculatory analyses of skin tissue throughout an observation period of 
up to two weeks [SORG et al., 2009; LASCHKE and MENGER, 2017b]. Technically, circular full-
thickness skin defects were created in the chamber observation window on the back of 
C57BL/6 wild-type mice and single layer Integra seeded with GFP+ ad-MVF isolated from 
transgenic C57BL/6 mice was implanted. Non-seeded implants served as controls. The in 
vivo experiments consisted of a 14 days-observation period with repetitive intravital 
fluorescence microscopy and stereomicroscopy for the assessment of the implants' 
vascularization and epithelialization. After 14 days, the implants were excised and processed 
for histological and immunohistochemical quantification of epithelialization, microvessel 
density and collagen content. There is increasing evidence that, beside a blood vascular 
network, the restoration of a functional lymphatic network is critical for the integration of skin 
substitutes [MARINO et al., 2014; FRUEH et al., 2018a]. Hence, the lymphatic vessel density of 
implanted Integra was also analyzed by means of immunohistochemistry. Of special interest, 
the GFP+/GFP- crossover approach allowed the identification of ad-MVF-derived blood and 
lymphatic vessels in the implants as well as in the surrounding skin. Finally, flow cytometry of 
isolated ad-MVF was performed for a detailed analysis of their cellular composition.  
 
The ultimate goal of Integra prevascularization is to shorten the timeframe until STSG 
coverage. This would reduce the risk of infection as well as the hospitalization time in the 
inpatient setting, presumably leading to a lower patient morbidity and to lower healthcare 
costs. Therefore, in the third study of this thesis, the value of ad-MVF-based 
prevascularization was investigated in a novel mouse model [FRUEH et al., 2018b]. In a first 
set of experiments, bilayer Integra seeded with ad-MVF was implanted into 8 mm-sized full-
thickness skin defects on the skull of CD1 nu/nu mice for 21 days. Non-seeded implants 
served as controls. From the clinician's perspective, these wounds mimic scalp defects with 
exposed bone after oncological tumor resection. The implants were assessed in situ by 
means of photo-acoustic imaging. At the end of the in vivo experiments, vascularization, 
lymphangiogenesis as well as incorporation of the implants were analyzed using trans-
illumination stereomicroscopy, histology and immunohistochemistry. In a second set of 
experiments, early (i.e., at day 10 after Integra implantation) STSG coverage of 
prevascularized and non-seeded implants was performed. For this purpose, autologous 
STSG were excised from the groin of CD1 nu/nu mice and fixed on the Integra implants on 
the skull of the animals. The survival rate of STSG was assessed by planimetry. At day 5 
after STSG transplantation the implants and the STSG were excised for histological and 
immunohistochemical analyses.  
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4. Aim of the Study 
 
The original articles of the present thesis represent a cumulative investigation on the novel 
application of ad-MVF-based prevascularization of the dermal skin substitute Integra. Each 
study addresses specific hypotheses. 
 
In the first study, published 2017 in the Journal of Visualized Experiments, the standardized 
isolation of ad-MVF from mouse epididymal fat is reported. The following questions were 
addressed: 
• What are the most critical technical steps of ad-MVF isolation? 
• Do ad-MVF-seeded Integra matrices exhibit the potential for in vivo application? 
 
In the second study, published 2017 in the Journal of Investigative Dermatology, the in vivo 
performance of ad-MVF-seeded Integra skin substitutes was investigated for the first time in 
the dorsal skinfold chamber of mice. The following questions were addressed: 
• Does prevascularized Integra exhibit a faster vascularization and a higher 
microvessel density when compared to non-seeded implants? 
• Does prevascularized Integra exhibit a higher lymphatic vessel density when 
compared to non-seeded implants? 
• Does improved vascularization and lymphangiogenesis of prevascularized Integra 
lead to faster integration of the implants? 
• Does improved vascularization and lymphangiogenesis of prevascularized Integra 
lead to faster epithelialization of the implants? 
 
In the third study, published 2018 in Scientific Reports, ad-MVF-prevascularization of 
Integra was taken to the next level and a proof-of-concept study with autologous skin grafting 
was performed in a novel mouse wound model. The goal of this study was to investigate 
whether the time-consuming two-staged skin reconstruction using Integra may be shortened 
with ad-MVF-seeding. The following questions were addressed: 
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• Is the harvesting of murine STSG possible? 
• Do the mice tolerate the dermal skin substitutes on the skull for 21 days? 
• Does ad-MVF-based prevascularization allow one-stage STSG coverage in mice? 
• Does ad-MVF-based prevascularization allow early STSG coverage in mice? 
• Do the STSG exhibit GFP+ (i.e. ad-MVF-derived) microvessels 5 days after 
transplantation? 






O r i g i n a l 	 A r t i c l e s 	|	16	
	
	
5. Original Articles 
 
 
1. Isolation of murine adipose tissue-derived microvascular 
fragments as vascularization units for tissue engineering  
Page 17 
2. Adipose tissue-derived microvascular fragments improve 
vascularization, lymphangiogenesis, and integration of dermal 
skin substitutes 
Page 24 
3. Prevascularization of dermal substitutes with adipose tissue-








































































































































































































































































































































































































of Dermal Skin Substitutes
Florian S. Frueh1,2, Thomas Später1, Nicole Lindenblatt2, Maurizio Calcagni2, Pietro Giovanoli2,
Claudia Scheuer1, Michael D. Menger1 and Matthias W. Laschke1
Full-thickness skin defects can be covered with dermal skin substitutes in combination with split-thickness skin
grafts. However, slow vascularization of the matrices bears the risk of wound infection and extends the length
of hospitalization. To overcome these problems, we describe a promising vascularization strategy. Green
fluorescent protein! adipose tissue-derived microvascular fragments (ad-MVF) were isolated from epididymal
fat pads of C57BL/6-Tg(CAG-EGFP)1Osb/J mice. ad-MVF were seeded on collagen-glycosaminoglycan matrices,
which were implanted into full-thickness skin defects in the dorsal skinfold chamber of wild-type C57BL/6 mice.
Nonseeded matrices served as controls. Vascularization, lymphangiogenesis, and integration of the implants
were studied by using intravital fluorescence microscopy, histology, and immunohistochemistry over 14 days.
ad-MVF rapidly reassembled into microvascular networks within the implants, which developed in-
terconnections to the host microvasculature. Accordingly, vascularization of the implants was markedly
accelerated, as indicated by a significantly higher microvessel density when compared with controls. Moreover,
dense lymphatic networks originating from the green fluorescent protein! ad-MVF developed within the
implants. This was associated with an improved implant integration. Hence, seeding ad-MVF on collagen-
glycosaminoglycan matrices represents a potential strategy to reduce morbidity and hospitalization of
patients undergoing the treatment of full-thickness skin defects.
Journal of Investigative Dermatology (2017) 137, 217e227; doi:10.1016/j.jid.2016.08.010
INTRODUCTION
The treatment of large full-thickness skin wounds represents a
major challenge in reconstructive surgery. Impaired skin
integrity due to mechanical or thermal trauma, tumor
resection, or systemic illness bears the risk of substantial
fluid loss, infection, and ultimate death (Clark et al., 2007).
Hence, the rapid re-establishment of the skin’s life-saving
barrier function is of pivotal importance. Autologous split-
thickness skin grafts (STSGs) provide reliable coverage.
However, they are prone to scarring and contracture
(Shevchenko et al., 2010). In addition, dermal and subcu-
taneous layers are destructed in deep wounds, which aggra-
vates the functional and esthetic disadvantages of STSGs.
To overcome these problems, bioengineered off-the-shelf
dermal skin substitutes, such as the U.S. Food and Drug
Administration-approved Integra (Integra Life Sciences,
Plainsboro, NJ), have been introduced (Burke et al., 1981).
Integra consists of a cross-linked bovine collagen and shark
glycosaminoglycan matrix covered with a silicone pseudo-
epidermis that protects the implant from exsiccation. In
clinical routine, Integra is directly implanted into the debri-
ded wound bed. After vascularization, the silicone pseudo-
epidermis is removed, and the dermal scaffold is covered
with STSG. A major drawback of this two-step procedure is
the fact that host vessel ingrowth into Integra requires up to 3
weeks (Debels et al., 2015). This delay of vascularization
bears the risk of wound infection and is associated with
extended patient hospitalization. Accordingly, there is a need
for an effective strategy that markedly accelerates the
vascularization of the dermal substitute.
Various angiogenic and prevascularization strategies have
been developed in the field of tissue engineering to improve
the survival of tissue substitutes (Auger et al., 2013; Laschke
et al., 2006; Laschke and Menger, 2016). Angiogenic
approaches focus on the stimulation of blood vessel ingrowth
into implants from the surrounding tissue. In line with this
concept, Reckhenrich et al. (2011) showed that the vascu-
larization of Integra is enhanced by incorporation of angio-
genic growth factors. However, the vascularization process
may still be too slow, because it is subject to the physiological
kinetics of angiogenesis with an average vessel growth rate of
only 5 mm/h (Utzinger et al., 2015). In contrast, prevascula-
rization approaches aim at the establishment of preformed
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microvascular networks within scaffolds before their im-
plantation (Athanassopoulos et al., 2012; Egaña et al., 2009;
Formigli et al., 2015; Meruane et al., 2012). These networks
are then rapidly perfused by developing interconnections to
the microvessels at the implantation site by inosculation
(Laschke et al., 2009). Nonetheless, the cell-based generation
of preformed microvascular networks requires time-
consuming in vitro cultivation and, thus, is not suitable for
intraoperative one-step procedures.
Recent studies indicate that adipose tissue-derived micro-
vascular fragments (ad-MVF) may represent a promising so-
lution to overcome the aforementioned problems (Laschke
et al., 2012; Pilia et al., 2014). In fact, ad-MVF are func-
tional vessel segments with a high vascularization capacity
that can be harvested in large amounts from fat tissue and
immediately transplanted without any further in vitro pro-
cessing (Laschke and Menger, 2015). Hence, we speculated
that ad-MVF may be suitable vascularization units for Integra
implants.
To test this hypothesis, ad-MVF from transgenic green
fluorescent protein (GFP)! donor mice were seeded on
Integra. The prevascularized matrices and nonseeded con-
trols were implanted into full-thickness skin defects in dorsal
skinfold chambers of wild-type recipient animals to analyze
their vascularization, lymphangiogenesis, and integration by
means of intravital fluorescence microscopy, histology, and
immunohistochemistry.
RESULTS
Isolation and cellular composition of ad-MVF
ad-MVF were enzymatically isolated from the epididymal fat
pads of male C57BL/6-Tg(CAG-EGFP)1Osb/J mice (Figure 1a
and b). This transgenic mouse line is transfected with
enhanced GFP cDNA under the control of a chicken b-actin
promoter and cytomegalovirus enhancer. Accordingly, all
tissues of these animals except red blood cells (RBCs) and
hair appear green under blue light excitation (Okabe et al.,
1997). From each donor animal, approximately 0.75 ml of
fat tissue was harvested for the isolation of approximately
30,000 ad-MVF.
The cellular composition of isolated ad-MVF was assessed
by means of flow cytometry. This analysis showed that the ad-
MVF contained 38.5 " 5.8% CD31! endothelial cells, 7.0 "
1.1% adipocyte-specific adhesion molecule! adipocytes,
and 65.0 " 2.6%, 7.0 " 0.5%, and 5.8 " 0.4% cells positive
for the stromal/stem cell surface markers CD29, CD90, and
CD117.
Implant seeding
ad-MVF from one donor animal were seeded on two 4-mm
Integra samples, which were cut out of a 1.3-mm-thick
Integra Dermal Regeneration Template Single Layer without
silicone sheet (Integra GmbH, Ratingen, Germany)
(Figure 1c). According to this protocol, approximately
120,000 ad-MVF isolated from approximately 3 ml of fat
tissue would be needed to seed 1 cm2 of Integra for the
treatment of larger skin defects. Histological and immuno-
histochemical analyses showed that ad-MVF were mainly
seeded on the matrices’ surfaces (Figure 1d) and consisted of
arteriolar, venular, and capillary vessel segments (Figure 1e).
Vascularization of the implants
For the in vivo analysis of prevascularized and nonseeded
control matrices we used a modified dorsal skinfold chamber
model, which was originally introduced by Sorg et al. (2007,
2009) for wound healing studies (Figure 1feh). For this pur-
pose, a 4-mm-sized full-thickness skin defect was created in
the observation window of the chamber (Figure 1g). The
defect included the skin and the underlying panniculus car-
nosus muscle while sparing the contralateral muscle layer
(Figure 1h). Immediately after defect preparation, the
matrices were implanted, and the observation window was
sealed with a removable cover glass.
Repetitive intravital fluorescence microscopy showed that
nonseeded Integra induced only a weak angiogenic host tis-
sue response and did not show a significant vessel ingrowth
except on the implants’ outer periphery throughout an
observation period of 14 days (Figure 2aec). In contrast,
seeding of Integra with ad-MVF resulted in the formation of
dense microvascular networks in the border and center zones
of the implants. These networks developed from the GFP! ad-
MVF, which rapidly interconnected with each other and the
surrounding host microvasculature, resulting in an early onset
of blood perfusion within the implants between days 3 and 6
(Figure 2del). Accordingly, the prevascularized implants
exhibited a significantly higher number of perfused regions of
interest (ROIs) and functional microvessel density between
days 6 and 14 compared with nonseeded controls (Figure 2k
and l).
Microhemodynamic analyses of microvessels in pre-
vascularized Integra showed typical signs of vascular matu-
ration and remodeling. At day 6, first blood-perfused
microvessels still presented with a rather large diameter of 33
mm, which progressively decreased to 17 mm at day 14
(Table 1). This was associated with a continuous increase of
the centerline RBC velocity and the wall shear rate over time.
In the nonseeded control group, microhemodynamic pa-
rameters could be assessed within only two implants at days
10 and 14, because the other implants did not exhibit
perfused microvessels on their surface throughout the 2-week
observation period (Figure 2k and l). Compared with pre-
vascularized Integra, the measurements showed a lower
centerline RBC velocity and wall shear rate (Table 1).
Additional histological analyses of the implants at day 14
confirmed our intravital microscopic findings. Hematoxylin
and eosin (HE)-stained tissue sections showed that nonseeded
control implants mainly contained invaded single cells
(Figure 3a), whereas the pores of prevascularized Integra
were completely filled with a well-vascularized granulation
tissue (Figure 3b). Immunohistochemical detection of CD31!
microvessels further showed a significantly increased
microvessel density within the prevascularized matrices
(Figure 3cee). This microvessel density was comparable to
that of the surrounding skin in the border zones of the im-
plants (Figure 3e). CD31/GFP co-staining showed that more
than 95% of the microvessels within the prevascularized
Integra were GFP!, indicating their origin from seeded ad-
MVF (Figure 3gej). The GFP! microvessels even invaded
the surrounding skin tissue, resulting in 47% GFP! micro-
vessels at the border of the implants (Figure 3j). In line with
these findings, additional immunohistochemical analyses
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Figure 1. In vivo analysis of vessel-seeded Integra. (a) Brightfield and (b) multifluorescence microscopy of a GFP! ad-MVF. Scale bars # 20 mm. (c) Seeding of
Integra with ad-MVF. (d) Hematoxylin and eosin-stained cross-section of Integra after the seeding process. The ad-MVF (arrowheads) are mainly seeded on the
implant’s surface. Scale bar # 130 mm. (e) The ad-MVF include (1) arterioles, (2) venules, and (3) capillaries, as shown by immunohistochemical detection of
CD31 and a-SMA. Scale bars in 1 and 3 # 35 mm; scale bar in 2 # 45 mm. (f) C57BL/6-mouse with a dorsal skinfold chamber. Scale bar # 20 mm. (g) Overview
of the chamber observation window with a full-thickness skin defect (diameter # 4 mm). Arrow # vessel of the contralateral panniculus carnosus muscle. Scale
bar # 5.8 mm. (h) Schematic cross-section of a dorsal skinfold chamber with implanted prevascularized Integra. ad-MVF, adipose tissue-derived microvascular
fragments; GFP, green fluorescent protein; SMA, smooth muscle actin.
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Figure 2. Intravital fluorescence microscopy. (aef) Chamber observation window with (aec) nonseeded and (def) prevascularized matrices after implantation
(d0) and at days 6 and 14 (blue light epi-illumination, 5% FITC-labeled dextran, 150,000 intravenously). Scale bars # 2.5 mm. (g) Insert of e highlighting the
onset of blood perfusion at day 6 (arrowhead # feeding vessel; arrows # perfused microvascular network; broken line # implant border; double arrow #
nonperfused, RBC-filled microvessels). Scale bar # 250 mm. (h) Insert of g (arrowheads # GFP! endothelium of the microvessels). Scale bar# 80 mm. (i, j) At day
10, the center of the implant is also perfused (area between broken and dotted line # multilayered epithelium). Scale bars: i # 500 mm, j # 120 mm. (k, l)
Perfused ROIs and functional microvessel density of nonseeded (white circles) and prevascularized Integra (black circles). Mean " standard error of the mean,
n # 8. *P < 0.05 versus nonseeded. d, day; GFP, green fluorescent protein; RBC, red blood cell; ROI, region of interest.
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showed that 9.5 " 1.0% of the CD31! endothelial cells
within the implants expressed the proliferation marker Ki67
(see Supplementary Figure S1 online).
Development of a lymphatic network within the implants
Additional immunohistochemical analyses included the
detection of lymphatic vessel endothelial hyaluronan recep-
tor (LYVE)-1! lymphatic vessels at the border and center of
the implants. Both nonseeded and prevascularized Integra
contained lymphatic vessels at day 14 after implantation.
However, the lymphatic vessel density was significantly
higher in prevascularized implants than in controls
(Figure 3f). LYVE-1/GFP co-staining further showed that more
than 60% of the lymphatic vessels within the prevascularized
implants originated from seeded ad-MVF (Figure 3ken). As
already observed for microvessels, GFP! lymphatic vessels
also invaded the surrounding host tissue at the border of the
implants (Figure 3n).
Collagen content of the implants
At day 14, Sirius red-stained sections were analyzed for the
visualization of mature collagen fibers (type I) within the
implants. Under polarized light, these fibers appear reddish
because of birefringence (Junqueira et al., 1979). Overall,
both nonseeded and prevascularized Integra contained rela-
tively low amounts of collagen fibers compared with healthy
skin (Figure 4aef). However, the collagen content was
significantly higher in prevascularized matrices when
compared with nonseeded controls (Figure 4f).
Epithelialization of the implants
In line with the improved vascularization and tissue inte-
gration, prevascularized Integra also exhibited an accelerated
epithelialization compared with nonseeded control implants
(Figure 5). Repetitive planimetric measurements of the epi-
thelialized implant surface area throughout the observation
period of 14 days showed a significantly enhanced epitheli-
alization of prevascularized matrices at days 10 and 14
(Figure 5aej). Vessel-seeded Integra exhibited slight hemor-
rhages after the onset of blood perfusion at day 6 after im-
plantation (Figure 5e and h). However, these focal bleedings
did not affect their epithelial coverage. These findings were
confirmed by additional immunohistochemical quantifica-
tion of cytokeratin! multilayered epithelium covering the
implants at day 14 (Figure 5kem).
Apoptotic cell death within the implants
Prevascularized Integra matrices were additionally analyzed
after implantation to clarify whether cell death occurred
within the implants. Immunohistochemical detection of the
apoptosis marker cleaved caspase-3 showed that the implants
contained 6.6 " 0.5% and 1.4 " 0.3% apoptotic cells at day
3 and day 14 (see Supplementary Figure S2 online).
DISCUSSION
The vascularization kinetics of implanted Integra determine
the time interval during which the wound is prone to infec-
tion and until STSG coverage is possible. We herein intro-
duce an approach that markedly reduces this critical phase
and, thus, may contribute to a reduction of patient morbidity
and hospitalization in the future treatment of full-thickness
skin defects. Indeed, we showed that the seeding with ad-
MVF rapidly results in blood perfusion of Integra within the
initial 3e6 days after implantation.
For our in vivo analyses, we used the mouse dorsal skinfold
chamber, as previously described by Michael et al. (2013a,
2013b). Contraction of the panniculus carnosus muscle,
which represents a problem in loose-skinned animal models
for wound healing (Griffin et al., 2015), is avoided in this
model by fixation of the skin between the two titanium
frames. Moreover, implanted matrices are protected from
exsiccation and manipulation by the animal in the closed
chamber (Michael et al., 2013b). Hence, it is not necessary to
regularly change wound dressings, which may influence the
healing process and jeopardize objective analyses. Accord-
ingly, we herein could use single-layer Integra without a
silicone sheet. This enabled us to study the vascularization of
the matrices by means of repetitive intravital fluorescence
microscopy over 14 days. In contrast to histological analyses,
this technique additionally allows the assessment of micro-
hemodynamic parameters. Thus, it is possible to determine
microvascular blood perfusion and vascular remodeling as
essential indicators for the functionality of the newly devel-
oping microvascular networks within the implants.
By harvesting ad-MVF from transgenic GFP! donor mice,
we could analyze their fate after implantation into GFPe
wild-type animals. Immunohistochemical analyses at the end
of the 14-day observation period showed homogenously
distributed GFP! microvessels within the implants, although
ad-MVF were initially seeded mainly on the superficial layers
of Integra. This indicates that they could rapidly invade the
matrix, which may have been supported by its relatively
loose architecture with pore sizes of 30e120 mm (Reiffel
et al., 2012; van der Veen et al., 2010). In addition, we
found that more than 95% of the microvessels within the
implants stained positive for GFP. Furthermore, the matrices
contained only low numbers of apoptotic cells at days 3 and
14 after implantation. These results confirm previous findings
that ad-MVF survive the isolation and transplantation well
and exhibit a unique capacity for rapidly reassembling into
new microvascular networks (Laschke et al., 2012, 2014).
Moreover, they release substantial amounts of angiogenic
Table 1. Microhemodynamic parameters of the
microvasculature within nonseeded (control)
and prevascularized Integra (ad-MVF)
d0 d3 d6 d10 d14
Diameter (mm)
ad-MVF — — 33.0 " 3.3 23.3 " 1.5 17.2 " 0.6
Control — — — 29.1 " 6.1 18.3 " 1.3
Centerline RBC
velocity (mm/s)
ad-MVF — — 83.2 " 16.2 374.3 " 61.1 489.0 " 73.1
Control — — — 166.6 " 102.6 167.3 " 97.7
Wall shear
rate (se1)
ad-MVF — — 21.4 " 5.1 129.9 " 20.1 230.2 " 35.4
Control — — — 53.9 " 39.4 76.3 " 47.9
ad-MVF (n # 8); control (n # 2); mean " standard error of the mean.
Abbreviations: ad-MVF, adipose tissue-derived microvascular fragment;
RBC, red blood cell.
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Figure 3. Vascularization and lymphatic network development. (a, b) Hematoxylin and eosin-stained sections of (a) nonseeded and (b) prevascularized
matrices at day 14. Scale bars # 500 mm. (c, d) Immunohistochemical detection of CD31! microvessels in (c) nonseeded and (d) prevascularized matrices at day
14. Scale bars # 90 mm. (e, f) Microvessel density and lymphatic vessel density within nonseeded (white bars) and prevascularized (black bars) Integra and
within the skin at the implants’ border. Mean " standard error of the mean, n # 8. *P < 0.05 versus nonseeded. (gei) Microvessels and (kem) lymphatic vessels
within a prevascularized matrix at day 14 (arrowheads # LYVE-1!/GFP! lymphatic vessels). Scale bars in gei and kem # 30 mm. (j, n) GFP! microvessels and
lymphatic vessels within prevascularized Integra and the skin at the implants’ border. Mean " standard error of the mean, n # 8. *P < 0.05 versus border. GFP,
green fluorescent protein; LYVE, lymphatic vessel endothelial hyaluronan receptor.
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growth factors, such as vascular endothelial growth factor
and basic fibroblast growth factor (Laschke et al., 2012). Their
high vascularization potential may have been further sup-
ported by mesenchymal stem cells, which are closely
attached within their physiological niche to the fragments
(McDaniel et al., 2014). Taken together, these factors may
have also contributed to the strong angiogenic sprouting
activity of the transplanted ad-MVF, which even grew out of
the matrices into the surrounding skin tissue, where they
developed interconnections with the host vessels by external
inosculation (Laschke et al., 2009).
The lymphatic system is critically involved in the drainage
of the interstitial space, and its failure leads to accumulation
of lymph and seroma formation (Frueh et al., 2016). Marino
et al. (2014) recently showed the importance of the
lymphatic system for bioengineered dermal-epidermal skin
grafts. They engineered a human lymphatic vascular network,
which successfully inosculated to the host lymphatic system
after transplantation into nude rats. However, so far there is
only limited knowledge about lymphangiogenesis within
implanted Integra (Cherubino et al., 2014). We found that
only a few lymphatic vessels had grown into nonseeded
Integra 14 days after implantation. In contrast, seeding of the
matrix with ad-MVF resulted in the development of
lymphatic networks, which consisted of 60% LYVE-1!/GFP!
lymphatic vessels. This indicates that ad-MVF do not only
represent effective vascularization units but may also be a
source of lymphatic endothelial cells or entire lymphatic
vessel fragments. In addition, it may be speculated that
fragment-associated mesenchymal stem cells exhibit the ca-
pacity of rapidly differentiating into lymphatic vessels after
transplantation. If this holds true, our findings may pave the
way for applications of ad-MVF in the field of lymphatic
tissue engineering and lymphedema therapy.
Figure 4. Collagen content of implanted Integra. (aee) Polarized light microscopy of Sirius red-stained sections of (a, d) nonseeded and (b, e) prevascularized
matrices and (c) adjacent skin at day 14 (a, b # overview; d, e # higher magnification of implant center; broken lines # implant borders). Scale bars: a, b # 500
mm; cee # 70 mm. (f) Total collagen ratio within nonseeded (white bar) and prevascularized Integra (black bar). Mean " standard error of the mean, n # 8. *P <
0.05 versus nonseeded. ad-MVF, adipose tissue-derived microvascular fragments.
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Figure 5. Epithelialization of implanted Integra. (aei) Stereomicroscopy in (aef) epi-illumination and (gei) transillumination of the chamber observation
window with (aec) nonseeded and (dei) prevascularized matrices after implantation (d0) and at days 6 and 14 (outer broken line # implant border; inner dotted
line # border of nonepithelialized area). Scale bars # 2.5 mm. (j) Epithelialization of nonseeded (white circles) and prevascularized Integra (black circles). Mean
" standard error of the mean, n # 8. *P < 0.05 versus nonseeded. (kem) Immunohistochemical detection of cytokeratin! multilayered epithelium (arrows)
covering a (k) nonseeded and (l) prevascularized matrix at day 14 after implantation. Scale bars # 250 mm. (m) Epithelial coverage of nonseeded (white bar) and
prevascularized Integra (black bar). Mean " standard error of the mean, n # 8. *P < 0.05 versus nonseeded. ad-MVF, adipose tissue-derived microvascular
fragments; d, day.
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Finally, we could show that the improved vascularization
of vessel-seeded Integra resulted in an enhanced tissue inte-
gration of the implants, as indicated by a significantly higher
collagen content when compared with nonseeded controls.
Moreover, the formation of a multilayered epithelium
covering the implants was markedly accelerated. This further
supports the idea of using ad-MVF to reduce the time period
until coverage of the implants by STSG to a minimum. Under
clinical conditions, this approach may have the advantage
that ad-MVF could be harvested minimally invasively from
lipoaspirated human fat tissue with low donor site morbidity.
Because ad-MVF represent fully functional vascularization
units, they could be directly seeded on Integra and retrans-
ferred to the patient in an intraoperative one-step procedure
without the need of prolonged in vitro incubation procedures
to stimulate blood vessel formation. In the future, this may be
achieved by means of automated closed-system devices, as
they are already available for the preparation of stem cell or
platelet-rich plasma products (Cohn et al., 2015;
Donnenberg et al., 2011).
This study shows that the seeding of Integra with ad-MVF
markedly improves the vascularization, lymphangiogenesis,
and integration of the dermal matrix during the initial 14 days
after implantation. Hence, this approach may contribute in
the future to reducing the infection risk and hospitalization of




Dorsal skinfold chambers were implanted in male wild-type
C57BL/6 mice (Institute for Clinical & Experimental Surgery,
Saarland University, Homburg/Saar, Germany) with an age of 4e6
months and a body weight of 24e28 g. Epididymal fat was harvested
from male C57BL/6-Tg(CAG-EGFP)1Osb/J mice (The Jackson Labo-
ratory, Bar Harbor, ME, USA) with an age of 12e18 months and a
body weight of 30 g or greater.
The animals were housed one per cage under a 12-hour day/night
cycle and were fed ad libitum with water and standard pellet food
(Atromin, Lage, Germany). The local governmental animal care
committee approved all experiments, which were conducted in
accordance with the European legislation on the protection of ani-
mals (Directive 2010/63/EU) and the National Institutes of Health
guidelines on the care and use of laboratory animals (National In-
stitutes of Health publication #85-23 Rev. 1985).
Isolation of ad-MVF
GFP! donor mice were anesthetized by intraperitoneal injection of
ketamine (75 mg/kg body weight; Ursotamin, Serumwerk Bernburg
AG, Bernburg, Germany) and xylazine (15 mg/kg body weight;
Rompun, Bayer, Leverkusen, Germany). After laparotomy, the ani-
mals were killed by incision of the abdominal aorta. The bilateral
epididymal fat pads were transferred into 10% DMEM (100 U/ml
penicillin, 0.1 mg/ml streptomycin; Biochrom, Berlin, Germany).
The fat was washed three times in phosphate buffered saline. The
tissue was minced with a fine scissors and digested in collagenase
NB4G (0.5 U/ml; Serva, Heidelberg, Germany) for 9 minutes while
being stirred under humidified atmospheric conditions (37 $C, 5%
CO2). After tissue digestion, the enzyme was neutralized with
phosphate buffered saline mixed with 20% fetal calf serum and the
cell-vessel suspension was incubated for 5 minutes at 37 $C. This
incubation cycle was repeated three to five times to remove the fat
supernatants after each cycle. The suspension was further filtered
once with a 500-mm mesh (pluriSelect Life Science, Leipzig,
Germany) to remove remaining fat clots. The suspension contained
GFP! ad-MVF that were enriched to a pellet by centrifugation for 5
minutes at 120g. Finally, the pellet was resuspended in phosphate
buffered saline containing 20% fetal calf serum to prevent aggluti-
nation of individual ad-MVF.
Flow cytometry
The cellular composition of ad-MVF was characterized by means of
flow cytometry. For this purpose, isolated ad-MVF from six male
C57BL/6 donor mice (pooled in three separate assays) were digested
in Accutase (BioLegend, Fell, Germany) for 30 minutes into single
cells. The cells were analyzed for the expression of the monoclonal
rat anti-mouse endothelial cell marker CD31-PE (BD Biosciences,
Heidelberg, Germany) and the monoclonal stromal/stem cell surface
markers rat anti-mouse CD117-FITC (BD Biosciences), mouse anti-
mouse CD90-FITC (BioLegend), and hamster anti-mouse CD29-
FITC (BioLegend). Isotype-identical rat IgG2ak-PE or IgG2ak-FITC
(BD Biosciences), mouse Ig1k-FITC (BD Biosciences) and hamster
IgG-FITC (BioLegend) served as controls. In addition, the cells were
analyzed for the expression of the polyclonal sheep anti-adipocyte
marker adipocyte-specific adhesion molecule (Bio-Techne, Wies-
baden, Germany) followed by a secondary donkey anti-sheep
IgG-Alexa488 antibody (Molecular Probes, Eugene, OR). Flow
cytometric analyses were performed by means of a FACScan (BD
Biosciences). Data were assessed using the software package Cell-
Quest Pro (BD Biosciences).
Implant seeding
Integra matrices were placed on a 500-mm cell strainer (pluriSelect,
Life Science), and 10 ml phosphate buffered saline containing ad-
MVF were transferred on the samples with a 100-ml pipette
(Eppendorf, Wesseling-Berzdorf, Germany). Negative pressure was
applied with a syringe to facilitate seeding of central areas.
Dorsal skinfold chamber model
To mount the chamber, the mice were anesthetized as described. A
detailed description of the implantation procedure is given in
Laschke et al. (2011). To prevent postoperative alterations of the
local microcirculation due to anesthesia and surgery, the animals
were allowed to recover for 48 hours before defect preparation and
matrix implantation.
Microscopy and microcirculatory analysis
The anesthetized animals were fixed on an acrylic glass stage, and
the dorsal skinfold chamber was positioned horizontally under a
stereomicroscope (Leica M651; Leica, Wetzlar, Germany) to quan-
tify the epithelial coverage of the implants by planimetry. The
chamber tissue was visualized by epi-illumination and trans-
illumination to identify epithelialized and nonepithelialized areas.
Epithelialization (given in percentage) was defined as (total implant
area) e (nonepithelialized implant area)/(total implant area) % 100.
For intravital fluorescence microscopy, 0.1 ml of 5% FITC-labeled
dextran (molecular weight # 150,000 Da; Sigma-Aldrich, Tauf-
kirchen, Germany) were injected retrobulbarily for contrast
enhancement by staining of the blood plasma. The observation
window was positioned under a Zeiss Axiotech microscope (Zeiss,
Oberkochen, Germany), and the images were transferred to a DVD
system for offline analysis (Ehrmantraut et al., 2010).
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Image analysis was performed with the software package
CapImage (Zeintl, Heidelberg, Germany). The vascularization of the
implants was assessed in 12 different ROIs. Perfused ROIs (in per-
centage of all ROIs) were defined as ROIs exhibiting either newly
developed RBC-perfused microvessels or GFP! ad-MVF. We further
assessed the functional microvessel density, that is, the length of all
RBC-perfused microvessels per ROI in cm/cm2. Finally, we measured
the diameter (d, in mm) and the centerline RBC velocity (v, in mm/s) of
40 randomly selected microvessels in ROIs with established blood
flow. To calculate the wall shear rate (y, in s-1), we used the Newto-
nian definition y # 8 % v/d (Ehrmantraut et al., 2010).
Experimental protocol
ad-MVF were harvested from four male C57BL/6-Tg(CAG-EGFP)
1Osb/J donor mice and seeded on eight Integra matrices. The pre-
vascularized matrices and eight nonseeded control matrices were
implanted into full-thickness skin defects in dorsal skinfold cham-
bers of 16 wild-type C57BL/6 mice. Epithelialization and vascular-
ization of the implants were analyzed using epi-illumination and
transillumination stereomicroscopy and intravital fluorescence mi-
croscopy directly after implantation (day 0) and at days 3, 6, 10, and
14. Finally, the animals were killed with an anesthesia overdose
and tissue specimens were further processed for histological and
immunohistochemical analyses.
In addition, ad-MVF were harvested from four male wild-type
C57BL/6 mice and seeded on eight Integra matrices. Four matrices
were directly processed for the histological assessment of the seed-
ing quality without in vivo implantation. The other four matrices
were implanted into four wild-type C57BL/6 mice for the immuno-
histochemical analysis of apoptotic cell death at day 3.
Histology and immunohistochemistry
Formalin-fixed tissue samples were embedded in paraffin and cut
into 3-mmethick sections. Individual sections were stained with
hematoxylin and eosin. To quantify the collagen content of the im-
plants, additional sections were stained with Sirius red. Using a
BX60 microscope (Olympus, Hamburg, Germany) and the imaging
software cellSens Dimension 1.11 (Olympus), the collagen content
in relation to normal skin was assessed in four ROIs of each sample.
For the immunohistochemical analysis of implant epithelializa-
tion, sections were stained with a polyclonal rabbit antibody against
cytokeratin (1:100, Abcam, Cambridge, UK) followed by a bio-
tinylated goat anti-rabbit IgG antibody (ready-to-use; Abcam). The
biotinylated antibody was detected by peroxidase-labeled strepta-
vidin (1:50; Sigma-Aldrich). 3-Amino-9-ethylcarbazole (Abcam) was
used as chromogen. The length of the cytokeratin! multilayered
epithelium and the diameter of the implants were measured to assess
epithelialization as (length of epithelium)/(total diameter of
implant) % 100.
Additional sections were stained with a monoclonal rat anti-
mouse antibody against CD31 (1:100; dianova GmbH, Hamburg,
Germany) and a polyclonal rabbit antibody against LYVE-1 (1:200;
Abcam). A goat anti-rat IgG-Alexa555 antibody (1:100; Molecular
Probes, Eugene, OR, USA) and a goat anti-rabbit IgG-Alexa555
antibody (1:200; Molecular Probes) served as secondary antibodies.
On each section, cell nuclei were stained with Hoechst 33342
(1:500; Sigma-Aldrich) to merge the images exactly. Quantitative
analyses of the sections included the determination of the micro-
vessel density and lymphatic vessel density within the implants and
the adjacent skin, that is, the border of the implants.
For the immunohistochemical differentiation between GFP! and
GFPe blood and lymphatic vessels, sections were stained with the
listed primary and secondary antibodies against CD31 and LYVE-1
and with a polyclonal goat anti-GFP antibody (1:100; Rockland,
Limerick, PA) to enhance GFP fluorescence. As secondary antibody
we used a biotin-labeled donkey anti-goat IgG antibody (1:15;
Jackson ImmunoResearch, Baltimore, MD), which was detected by
fluorescein labeled-streptavidin (1:50; Vector Labs, Burlingame, CA).
For this purpose, the sections were placed in Coplin jars with 0.05%
citraconic anhydride solution (pH 7.4) for 1 hour at 98 $C and then
incubated overnight at 4 $C with the primary antibody, followed by
the secondary antibody at 37 $C for 2 hours. The fractions of GFP!
and GFPe blood and lymphatic vessels within the implants and the
adjacent skin were assessed using the BX60 microscope.
For the characterization of freshly seeded ad-MVF, sections were
stained with a monoclonal mouse anti-mouse antibody against
a-smooth muscle actin (1:100; Sigma-Aldrich) followed by a
secondary peroxidase-labeled goat anti-mouse antibody (1:200;
dianova GmbH).
Statistics
Data were tested for normal distribution and equal variance. Dif-
ferences between two groups were analyzed using the unpaired
Student t test (SigmaStat; Jandel Corporation; San Rafael, CA). All
values are expressed as mean " standard error of the mean. Statis-
tical significance was accepted for values of P < 0.05.
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derived microvascular fragments 
enhances early skin grafting



























Full-thickness skin defects with impaired vascularization are a reconstructive challenge. !ese wounds are typ-
ically encountered when treating diabetic ulcers, burn injuries, or a"er tumor resection1. In the United States, 
around 6.5 million patients are a#ected by chronic wounds and the burden is growing due to an aging pop-
ulation and rising incidence of diabetes and obesity2. !us, there is an on-going need to develop innovative 
wound-healing strategies.
!e treatment of bradytrophic wounds with split-thickness skin gra"s (STSG) alone is rarely successful, 
because the underlying tissues do not exhibit a su$cient vascularization capacity. Moreover, STSG without der-
mal support are prone to extensive scarring and contraction3. To overcome these problems, bioengineered dermal 
substitutes have been introduced. !e FDA-approved Integra (Integra Life Sciences, Plainsboro, NJ, USA) con-
sists of a collagen-glycosaminoglycan matrix with a silicone pseudo-epidermis and is frequently used in clinical 
practice4. However, microvascular network formation within the matrix requires up to 3 weeks before STSG 
coverage can be performed5. !is vascularization kinetics crucially determines the risk of wound infection, which 
is elevated as long as the physiological barrier of the skin is not re-established6.
The vascularization of dermal substitutes can be improved by means of angiogenic or prevasculariza-
tion approaches7. Prevascularization based on the seeding of adipose tissue-derived microvascular fragments 
(ad-MVF) is particularly suitable for intraoperative one-step procedures and, therefore, a promising strategy 
for future clinical application8,9. Ad-MVF are functional vessel segments that rapidly reassemble into microvas-
cular networks a"er transplantation10. Recently, we demonstrated that the prevascularization of Integra with 
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networks within the matrix11. !ese results led to the hypothesis that ad-MVF seeding may also accelerate the 
integration and vascularization of Integra in bradytrophic wounds, which may then allow early skin gra"ing.
To test this hypothesis, we used a full-thickness skin defect model on the skull of mice, mimicking 
bradytrophic wounds a"er tumor resection on the human scalp. Implanted non-seeded and prevascularized 
Integra matrices were assessed for 21 days using stereomicroscopy, photo-acoustic imaging, histology and immu-
nohistochemistry. In a subsequent proof-of-principle experiment, coverage with autologous STSG was performed 
10 days a"er Integra implantation and the gra"s’ survival was analyzed.
Results
Full-thickness skin defect model. Ad-MVF were isolated from green %uorescent protein (GFP)+ donor 
mice and seeded onto Integra as previously described11,12 (Fig.&1a). Non-seeded Integra served as control. To ana-
lyze the vascularization and incorporation of the matrices, full-thickness skin defects were prepared on the skull 
of CD1 nu/nu mice. For this purpose, we modi'ed the head punch model13,14 and prepared an 8 mm skin defect 
Figure 1. Animal model, photo-acoustic imaging and trans-illumination stereomicroscopy. (a–c) A"er the 
seeding process (a), the matrices were implanted into full-thickness skin defects on the skull of CD1 nu/nu mice 
(b and c). (d–g) B-mode ultrasound (d and f) and OxyHemo-mode photo-acoustic imaging (e and g) of non-
seeded (d and e) and prevascularized (f and g) Integra 21 days a"er implantation. Red areas = high oxygenation, 
blue areas = low oxygenation, arrowheads in f = frontal calvaria, asterisks in f = dorsal acoustic attenuation 
(sutures), broken line in e and g = implants. (h) Quanti'cation of sO2 (%). Mean ± SEM, n = 8, **P < 0.001 vs. 
non-seeded control. (i–n) Epi-illumination (i and l) and trans-illumination (j and m) microscopy with digital 
segmentation images (k and n) of non-seeded (i–k) and prevascularized (l–n) Integra. (o) Quanti'cation of 
vascularized area (% of total implant area). Mean ± SEM, n = 8, *P < 0.05 vs. non-seeded control. Scale bars: 
c = 2.5 mm, d–g = 1.8 mm, i–n = 2 mm.
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on the crown of the skull. !e periosteum was resected to create a poorly vascularized, bradytrophic wound bed. 
To ensure implant immobilization, a titanized mesh was placed on the bone overlapping the wound edges accord-
ing to a published model15. Subsequently, non-seeded and ad-MVF-seeded (prevascularized) Integra matrices 
were implanted and secured with sutures (Fig.&1b and c).
Photo-acoustic imaging and trans-illumination stereomicroscopy. Photo-acoustic imaging was 
performed to quantify in situ the oxygen saturation within the neo-dermis of non-seeded and prevascularized 
Integra 21 days a"er implantation. !is approach revealed that prevascularized matrices were characterized by 
signi'cantly higher oxygenation levels than non-seeded controls (Fig.&1d–h).
In a next step, the implants were excised and assessed using trans-illumination stereomicroscopy to objectify 
microvascular network formation. In line with the photo-acoustic results, this analysis revealed a signi'cantly 
reduced vascularization in non-seeded controls when compared to matrices seeded with ad-MVF (Fig.&1i–o).
Histology and immunohistochemistry. Histological analyses of the implants showed that non-seeded 
Integra was characterized by a low cellular in'ltration (Fig.&2a). In contrast, the neo-dermis of prevascularized 
Integra exhibited a dense granulation tissue (Fig.&2b). Accordingly, the integration of the prevascularized matrices 
was markedly enhanced, as indicated by signi'cantly more mature Sirius red stained collagen 'bers when com-
pared to non-seeded controls (Fig.&2c–f).
Immunohistochemical detection of the endothelial cell marker CD31 demonstrated that the prevascularized 
matrices exhibited a 3.5-fold higher microvessel density 21 days a"er implantation when compared to non-seeded 
controls (Fig.&2g–j). GFP/CD31 co-staining further revealed that > 95% of the microvessels within the prevascu-
larized implants were GFP+. Moreover, the lymphatic vessel density of prevascularized implants was markedly 
increased (Fig.&2k–n). However, compared to the microvasculature, a lower fraction of lymphatic vessels exhibited 
a GFP+ signal (88 ± 1%).
Figure 2. Histology and immunohistochemistry. (a and b) HE-stained sections of non-seeded (a) and 
prevascularized (b) implants. Broken line = implant border, arrowheads = mesh 'bers. (c–e) Polarized light 
microscopy of Sirius red-stained sections of normal skin (c), non-seeded (d) and prevascularized (e) Integra. 
(f) Quanti'cation of total collagen ratio (implant/skin). Mean ± SEM, n = 8, **P < 0.001 vs. non-seeded 
control. (g–i and k–m) Immunohistochemical staining of microvessels (g–i, white arrowhead = CD31+/
GFP+ microvessel) and lymphatic vessels (k–m, white arrowhead = LYVE-1+/GFP+ lymphatic vessel, empty 
arrowhead = LYVE-1+/GFP! lymphatic vessel) within prevascularized Integra 21 days a"er implantation.  
(j and n) Quanti'cation of microvessel density (mm!2) and lymphatic vessel density (mm!2). Mean ± SEM, 
n = 8, **P < 0.001 vs. non-seeded control. Scale bars: a and b = 800 µm, c–e = 20 µm, g–i = 20 µm, k–m = 30 µm.
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Ǥ In additional experiments, we analyzed the survival of autologous STSG, which 
were transplanted onto non-seeded and prevascularized Integra 10 days a"er implantation. Full-thickness skin 
gra"s (Fig.&3a) were harvested from the groin of CD1 nu/nu mice and defatted to imitate STSG (Fig.&3b). !e STSG 
were then transplanted onto the matrices and secured with sutures. To protect the STSG from exsiccation, a sterile 
plastic dressing (Fig.&3c) and a second titanized mesh were 'xed to the previously implanted mesh (Fig.&3d and e).

Ǥ !e survival of the STSG was assessed by planimetric 
analyses 5 days a"er transplantation. STSG on prevascularized Integra exhibited a survival rate of 40 ± 11%. 
In contrast, skin gra"ing on non-seeded controls resulted in a signi'cantly lower transplant survival of 5 ± 5% 
(Fig.&3f–j).
Histological analyses revealed that dermal thickness and hierarchical integrity of the STSG were more pre-
served in the prevascularized group when compared to controls (Fig.&3k and l). Moreover, the transplantation 
of STSG on prevascularized implants also resulted in a thicker cytokeratin+ epidermis (Fig.&3m and n). Finally, 
immunohistochemical GFP/CD31 co-staining was performed for a qualitative assessment of cell migration into 
the STSG. Of interest, we detected a few GFP+ cells, which were incorporated into the CD31+ endothelium of 
individual microvessels (Fig.&3o–q).

!e treatment of bradytrophic skin defects is a major challenge. In the last decade, skin tissue engineering has 
evolved dramatically with promising approaches to manage di$cult wounds16. In fact, preconditioned hydro-
gels17–19, microporous gels20 or engineered cell sheets21,22 exhibit a tremendous wound healing potential in the 
preclinical setting. However, the majority of these techniques involves complex in vitro steps and, thus, is not 
suitable for intraoperative one-step procedures. Hence, straightforward strategies need to be developed.
We have recently introduced ad-MVF-seeded Integra as a powerful strategy to treat full-thickness skin 
defects11. In the present study, we further evaluated this approach in a murine wound model with early STSG 
coverage. For this purpose, we used hairless CD1 nu/nu mice, because they enabled the application of compres-
sive wound dressings and photo-acoustic imaging without the need for repetitive mechanical and chemical skin 
depilation, which may have markedly a#ected the incorporation of the implanted matrices and the engra"ment 
of STSG. In addition, these immunoincompetent animals allowed the transplantation of ad-MVF from GFP+ 
donor mice without inducing a rejection reaction. Hence, it was possible to identify GFP+ ad-MVF-derived and 
GFP- host-derived blood and lymphatic vessels within the implanted matrices. On the other hand, it should be 
considered that CD1 nu/nu mice lack a thymus and, thus, are unable to produce T-cells. Importantly, epidermal 
and dermal T-cells are crucially involved in the regulation of murine wound healing by local production of epi-
thelial growth factors and in%ammatory cytokines23–26. Moreover, human epidermal T-cells have been shown 
to contribute to the e#ective healing of acute wounds and are functionally defective in patients with chronic 
wounds27,28. Accordingly, it can be assumed that the implantation of ad-MVF-seeded matrices into immunocom-
petent animals might have even resulted in an improved vascularization and incorporation of the implants when 
compared to the herein reported results. !is further underlines the high potential of ad-MVF for applications 
in regenerative medicine.
To create full-thickness skin defects with a poorly vascularized wound bed, we combined two mouse mod-
els13,15. Even though the literature negates wound contraction in the head punch model29 we observed implant loss 
without additional stabilization. Hence, we used a titanized mesh to secure the dermal substitute. Importantly, we 
did not observe signi'cant foreign body reactions around the mesh. In our model, the surrounding skin margin 
represented the only site for ad-MVF inosculation or angiogenic ingrowth.
Photo-acoustic imaging and trans-illumination stereomicroscopy showed a signi'cantly higher oxygenation 
and vascularization in the prevascularized matrices when compared to non-seeded controls. Accordingly, we 
also measured an increased microvessel density. Moreover, >95% of the microvessels within the prevascularized 
implants were GFP+, indicating that they originated from the seeded ad-MVF. !is 'nding is important, because 
in contrast to previous studies11,30,31 we herein used the double-layer Integra, which is covered with a silicone 
sheet. Hence, ad-MVF could only be seeded on the bottom side of the matrices and were implanted in direct con-
tact to the bone of the mouse skull. Nonetheless, GFP+ microvessels were homogeneously distributed in deep and 
super'cial layers of the matrices at day 21 a"er implantation. !is suggests that the ad-MVF even survive in an 
initially poorly oxygenated environment and rapidly reassemble into new microvascular networks, most probably 
driven by hypoxia-induced secretion of angiogenic growth factors.
!e two-staged treatment of bradytrophic skin defects with dermal substitutes and STSG is a common proce-
dure in clinical practice. To further unravel the potential of prevascularization with ad-MVF, we assessed the fate 
of autologous STSG in a proof-of-principle experiment. !e application of STSG in mice is technically demand-
ing due to the small animal size and thin skin. Because conventional STSG harvesting is not feasible, we micro-
surgically removed the panniculus carnosus muscle and the deep dermal layer of excised skin samples. !is 
resulted in skin gra"s similar to STSG. !e compression of these gra"s was the major prerequisite for successful 
engra"ment. For this purpose, we 'xed them with a titanized mesh, which was well tolerated by the animals. No 
gra" was lost due to manipulation. In pilot experiments, we performed STSG coverage already at day 0, i.e. imme-
diately a"er the implantation of Integra. However, this one-step procedure was not e#ective with complete gra" 
necrosis. !is may be explained by the fact that the onset of blood perfusion in ad-MVF-derived microvascular 
networks requires 3–6 days11. Consequently, we decided to cover the implants at day 10. At this time point, the 
neo-dermis of the prevascularized matrices was stable and allowed STSG coverage. Importantly, gra" survival in 
the prevascularized group was signi'cantly improved when compared to non-seeded controls.
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Figure 3. Autologous skin gra"ing. (a–e) HE-stained sections of a skin gra" before (a) and a"er (b) defatting. 
!e autologous gra"s are transferred onto implanted Integra and are secured with sutures, a sterile plastic 
dressing (c) and a titanized mesh (d and e). (f–i) Stereomicroscopy of non-seeded (f and g) and prevascularized 
(h and i) implants immediately (f and h) and 5 days (g and i) a"er skin gra"ing. (j) Quanti'cation of skin gra" 
survival (% of total transplant) 5 days a"er transplantation. Mean ± SEM, n = 6, *P < 0.05 vs. non-seeded 
control. (k and l) HE-stained sections a"er skin gra"ing of non-seeded (k) and prevascularized (l) Integra. 
Double arrows = gra" thickness. (m and n) Immunohistochemical detection of cytokeratin+ epithelium  
(n, arrowhead) a"er gra"ing of a non-seeded (m) and prevascularized (n) matrix. (o–q) Immunohistochemical 
detection of CD31+ microvessels (o and q, white arrowheads) within a skin gra" 5 days a"er transplantation 
on prevascularized Integra. CD31/GFP co-staining reveals CD31+/GFP+ cells (p and q, empty arrowheads) 
involved in microvessel formation. Scale bars: a and b = 120 µm, c = 3 mm, d = 9 mm, f–i = 1.8 mm, k–n =  
80 µm, o–q = 35 µm.
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Previous experiments with full-thickness skin gra"s in the dorsal skinfold chamber model revealed that blood 
vessel ingrowth from the wound bed crucially contributes to gra" revascularization32,33. In these studies, reperfu-
sion was established ~3 days a"er transplantation and subsequently, an angiogenic response was detected within 
the skin gra"s’ capillaries. Of interest, angiogenesis started in the center of the gra"s, indicating that the hypoxic 
stimulus may be most prominent in this area33. Accordingly, our study also revealed gra" survival mainly in the 
center of the transplants. !is 'nding was consistent in all vital gra"s and supports the theory of hypoxia-induced 
angiogenesis in central parts of STSG.
Ad-MVF are a rich source of regenerative cells. In fact, they contain a relevant fraction of Sca-1+/VEGFR-2+ 
endothelial progenitor cells10,34. !ese cells boost wound revascularization and reoxygenation in mice35. To ana-
lyze cellular interactions between the wound bed and the skin gra"s, co-staining with CD31/GFP was performed. 
Indeed, we could show that GFP+ cells incorporated into the CD31+ endothelium of individual microvessels 
within the STSG. Hence, it can be assumed that the revascularization of the gra"s was achieved by external ino-
sculation, i.e. the outgrowth of the gra"s’ microvessels into the surrounding skin36, and by the ingrowth of GFP+ 
ad-MVF-derived vascular sprouts from the prevascularized matrices. However, this conclusion may not com-
pletely explain the advantageous e#ect of prevascularized Integra on the survival rate of STSG. As indicated by 
photo-acoustic imaging, the prevascularized matrices exhibited a signi'cantly higher oxygen level. Consequently, 
we speculate that the ~200 µm thick skin gra"s on ad-MVF-enhanced neo-dermis were supplied by di#usion with 
life-sustaining oxygen and growth factors to bridge the critical 48–72 h a"er implantation.
Beside a sufficient vascularization, lymphatic vessel formation is essential to re-establish skin function. 
Dermal lymphatic vessels are crucially involved in the regulation of tissue %uid homeostasis and immune cell 
tra$cking37. Adipose tissue-derived stem cells have shown potential to support lymphangiogenesis in vitro38 and 
in vivo39. To assess lymphangiogenic e#ects within non-seeded and prevascularized Integra, we quanti'ed the 
lymphatic vessel density 21 days a"er implantation. We found that prevascularized Integra contained >3-fold 
more lymphatic vessels than non-seeded controls. We hereby con'rm the recently observed lymphangiogenic 
e#ect of ad-MVF11. Finally, lymphatic vessels play an important role in the engra"ment of STSG. However, to 
observe lymphatic anastomoses between STSG and the wound bed, up to 14 days observation a"er gra"ing are 
required18. Accordingly, within the short observation period of 5 days, we were not able to detect lymphatic inter-
connections in the present study.
In conclusion, this study indicates that ad-MVF represent powerful vascularization units. Seeded on dermal 
substitutes, they enhance the vascularization and incorporation of dermal substitutes in skin defects exhibiting a 
bradytrophic wound bed. In addition, they allow the early coverage of Integra with STSG. Hence, they may mark-
edly contribute to shorten the time frame needed for future skin reconstruction and, thus, to reduce the infection 
risk and hospitalization times for patients.

Ǥ Full-thickness skin defects were prepared in CD1 nu/nu mice (age: ~3 months, body weight: 
30–32 g). Ad-MVF were isolated from C57BL/6-Tg(CAG-EGFP)1Osb/J mice (age: 7–12 months, body weight: 
>30 g; !e Jackson Laboratory, Bar Harbor, ME, USA)40. !e animals were housed under a 12 h light/dark cycle 
and received water and standard food pellets (Altromin, Lage, Germany) ad libitum.
All experiments were approved by the local governmental animal care committee (Landesamt für 
Verbraucherschutz, Saarbrücken, Germany; permit number: 25/2016) and conducted in accordance with the 
European legislation on the protection of animals (Directive 2010/63/EU) and the National Institutes of Health 
(NIH) guidelines on the care and use of laboratory animals (NIH publication #85–23 Rev. 1985).
Ǧ	Ǥ Epididymal fat pads were harvested from GFP+ donor mice, transferred into 10% 
Dulbecco’s modi'ed eagle medium (DMEM; 100 U/mL penicillin, 0.1 mg/mL streptomycin; Biochrom GmbH, 
Berlin, Germany), and washed with phosphate-bu#ered saline (PBS; Biochrom GmbH). !e fat was mechanically 
minced and digested for 10 min with collagenase NB4G (0.5 U/mL; Serva Electrophoresis GmbH, Heidelberg, 
Germany) while stirring under humidi'ed atmospheric conditions (37 °C, 5% CO2). !e digestion was neutral-
ized with PBS supplemented with 20% fetal calf serum (FCS; Biochrom GmbH) and the cell-vessel suspension 
was incubated for 5 min at 37 °C. A"er removal of fat supernatant, the remaining cell-vessel suspension was 
'ltered through a 500 µm mesh (pluriStrainer; pluriSelect Life Science, Leipzig, Germany) and centrifuged for 
5 min at 600 " g to obtain a pellet.
Seeding of Integra. Dermal substitutes (diameter: 8 mm) were cut out of Integra Dermal Regeneration 
Template (Integra Life Sciences, Ratingen, Germany) with a biopsy punch. For each recipient mouse, a pellet con-
taining ~ 40,000 GFP+ ad-MVF isolated from 1 mL fat tissue was mixed with 20 µL 0.9% NaCl and was seeded on 
the collagen-glycosaminoglycan surface of Integra with a 20 µL precision pipette (Eppendorf, Wesseling-Berzdorf, 
Germany). !e same procedure without ad-MVF was performed for non-seeded implants of the control group.
Full-thickness skin defect model. CD1 nu/nu mice were anesthetized by intraperitoneal injection of ket-
amine (75 mg/kg; Ursotamin, Serumwerk Bernburg AG, Bernburg, Germany) and xylazine (15 mg/kg; Rompun, 
Bayer, Leverkusen, Germany) and were placed under a stereomicroscope (Leica M651, Wetzlar, Germany). 
Subsequently, a skin defect on the crown of the skull was prepared using an 8 mm biopsy punch and the perios-
teum was resected with microsurgical instruments. A titanized mesh (TiMesh; pfm medical AG, Köln, Germany) 
was placed on the bone overlapping the wound edges. Next, non-seeded and prevascularized Integra matrices 
were implanted and secured with interrupted 6/0 mono'lament. Postoperative analgesia was provided for 3 days 
with tramalhydrochloride (40 mg/100 mL drinking water; Grünenthal GmbH, Aachen, Germany).
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For the transplantation experiments, full-thickness skin gra"s were excised from the right groin of anesthe-
tized CD1 nu/nu mice and defatted under a stereomicroscope. !e STSG were transplanted onto the Integra 
matrices and secured with interrupted 6/0 mono'lament. Finally, a sterile plastic dressing and a second titanized 
mesh were 'xed to the previously implanted mesh with interrupted 5/0 mono'lament.
Ultrasound and photo-acoustic imaging. Ultrasound and photo-acoustic imaging using a Vevo 
LAZR system (FUJIFILM VisualSonics Inc., Toronto, ON, Canada) and a real-time microvisualization LZ550 
linear-array transducer (FUJIFILM VisualSonics Inc.) with a center frequency of 40 MHz was performed to 
detect hemoglobin oxygen saturation (sO2) within non-seeded and prevascularized Integra. Twenty-one days 
a"er implantation, the animals were anesthetized with 1.5% iso%urane and positioned in prone position on a 
heated stage. Sterile ultrasound gel was applied to avoid air interference with ultrasound coupling into the animal.
For three-dimensional high-resolution B-mode ultrasound and OxyHemo-mode photo-acoustic imaging, the 
scanhead was driven over the entire implant by a linear motor to acquire two-dimensional images at parallel and 
uniformly spaced, 150 µm-sized intervals. Oxy-Hemo-mode photo-acoustic images were recorded at 750 nm and 
850 nm with a two-dimensional gain of 40 dB to detect sO2 within the samples41,42. Values were computed using 
the Vevo LAB 1.7.2. so"ware (FUJIFILM VisualSonics Inc.).
ǦǦǤ !e implants and the surrounding skin were excised at 
day 21, placed under the stereomicroscope and digital images in TIF format were recorded. Using the so"ware 
package ImageJ43 the background was subtracted and the images were converted into binary black and white 
images allowing the quanti'cation of the vascular network. !e vascularization (given in %) was de'ned as (vas-
cularized area/total implant area) ! 100.
Planimetric analyses based on repetitive in vivo epi-illumination microscopy were performed to quantify the 
survival of the skin gra"s. For this purpose, the anesthetized mice were placed under the stereomicroscope and 
digital images in TIF format were recorded. Using ImageJ, the survival of the skin gra"s (given in %) was evalu-
ated as follows: (Vital skin gra" area/total skin gra" area) ! 100.
Ǥ Ad-MVF of 8 GFP+ donor mice were isolated and seeded onto 8 Integra matrices. 
!e matrices were implanted for 21 days into full-thickness skin defects on the skull of CD1 nu/nu mice. Eight 
non-seeded implants served as controls. In vivo imaging of the matrices was performed using epi-illumination 
stereomicroscopy (day 0, 3, 7, 14 and 21) and ultrasound/photo-acoustic imaging (day 21). At day 21, the animals 
were sacri'ced and trans-illumination stereomicroscopy was performed. Finally, the specimen were processed for 
histological and immunohistochemical analyses.
In additional experiments, ad-MVF of 6 GFP+ donor mice were seeded onto Integra and the dermal substi-
tutes were covered with STSG 10 days a"er implantation into skin defects of CD1 nu/nu mice. Six non-seeded, 
STSG-covered implants served as controls. !e gra"s were assessed by epi-illumination stereomicroscopy directly 
a"er implantation and at day 5. !e animals were killed and the specimen were processed for histological and 
immunohistochemical analyses.
Histology and immunohistochemistry. Formalin-'xed tissue samples were embedded in para$n and 
cut into 3-mm thick sections. Sections were stained with hematoxylin and eosin (HE) or Sirius red for the vis-
ualization of mature collagen 'bers (type I)44. With a BX60 microscope (Olympus, Hamburg, Germany) and 
the imaging so"ware cellSens Dimension 1.11 (Olympus), the collagen content in relation to normal skin was 
assessed in 3 regions of interest (ROIs) of each sample.
Additional sections were stained with a monoclonal rat anti-mouse antibody against CD31 (1:100; dianova 
GmbH, Hamburg, Germany) and a polyclonal rabbit antibody against lymphatic vessel endothelial hyaluronan 
receptor-1 (LYVE-1; 1:200; Abcam, Cambridge, UK). A goat anti-rat IgG-Alexa555 antibody (1:100; Molecular 
Probes, Eugene, OR, USA) and a goat anti-rabbit IgG-Alexa555 antibody (1:200; Molecular Probes) served 
as secondary antibodies. Cell nuclei were stained with Hoechst 33342 (2 µg/mL; Sigma-Aldrich, Tau(irchen, 
Germany). !e density of CD31+ blood and LYVE-1+ lymphatic vessels (given in mm!2) and the fraction of 
CD31+/GFP+ blood and LYVE-1+/GFP+ lymphatic vessels (given in %) were assessed within 5 ROIs of each 
implant.
To di#erentiate between GFP+ and GFP- blood and lymphatic vessels, sections were stained with the men-
tioned primary and secondary antibodies against CD31 and LYVE-1 and with a polyclonal goat anti-GFP anti-
body (1:100; Rockland, Limerick, PA) to enhance GFP %uorescence. A biotin-labeled donkey anti-goat IgG 
antibody (1:15; Jackson ImmunoResearch, Baltimore, MD) was used as secondary antibody and was detected 
by %uorescein labeled-streptavidin (1:50; Vector Labs, Burlingame, CA). For this purpose, sections were placed 
in Coplin jars with 0.05% citraconic anhydride solution (pH 7.4) for 1 h at 98 °C and incubated overnight at 4 °C 
with the primary antibody, followed by the secondary antibody at 37 °C for 2 h. Finally, the fraction of GFP+ and 
GFP- blood and lymphatic vessels was assessed.
For the immunohistochemical assessment of STSG epithelialization, sections were stained with a polyclonal 
rabbit antibody against cytokeratin (1:100; Abcam). As secondary antibody a biotinylated goat anti-rabbit 
IgG antibody (ready-to-use; Abcam) was used, which was detected by peroxidase-labeled-streptavidin (1:50; 
Sigma-Aldrich). 3-Amino-9-ethylcarbazole (Abcam) was used as chromogen. !e sections were counterstained 
with Mayer’s hemalum solution (Merck, Darmstadt, Germany).
Statistics. Data were tested for normal distribution and equal variance. Di#erences between groups were 
analyzed using the unpaired Student t test (SigmaPlot; Systat So"ware Inc, San Jose, CA, USA). All values are 
expressed as mean ± standard error of the mean (SEM). Statistical signi'cance was accepted for values of P < 0.05.
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Ǥ !e datasets generated and/or analyzed during the current study are available from the 
corresponding author on reasonable request.
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6.1 Discussion of Material and Methods 
6.1.1 Isolation of ad-MVF 
After the first description in rats in 1972 [WAGNER et al., 1972; WAGNER and MATTHEWS, 
1975], the isolation of ad-MVF from murine adipose tissue has only recently been introduced 
in tissue engineering. Mouse ad-MVF are more versatile when compared with rat isolates, 
because the use of different transgenic strains may allow insights into molecular 
mechanisms after ad-MVF transplantation. The enzymatic isolation of ad-MVF from mouse 
epididymal fat pads is a straightforward procedure with a few critical steps. The murine body 
exhibits several extra- and intraabdominal fat deposits. In the present thesis the epididymal 
fat was chosen as adipose source, because it exhibits several important advantages when 
compared to subcutaneous fat deposits: First, the epididymal fat pads are bigger and better 
definable when compared to the more diffuse subcutaneous fat layer. Second, they are 
characterized by a homogeneous tissue structure and lack larger blood vessels, which 
reduces the contamination with fibrotic tissue. Finally, the axillary and inguinal subcutaneous 
fat also contains numerous lymphatic structures, such as lymphatic collectors and lymph 
nodes that represent an additional source for ad-MVF contamination. However, the harvest 
of epididymal fat pads is invasive and requires a laparotomy. The procedure should be 
performed under magnification by means of surgical loops or a stereomicroscope for a 
reliable identification of the adipose tissue, the epididymis and the testes. It is crucial to 
preserve a safety margin of a few mm between the epididymal fat and the spermatic 
structures to prevent sample contamination by accidental excision of the epididymis. Another 
source of contamination is the abdominal fur. To 
ensure sterility, the abdominal skin should be dissected 
free of the underlying muscles prior to the laparotomy. 
The total time required for the simple surgical 
procedure is ~ 20 min. The subsequent isolation of ad-
MVF consists of mechanical mincing, enzymatic 
digestion, filtration and, finally, centrifugation and can 
be performed within 90 - 120 min. The most crucial step 
of the in vitro procedure is to judge whether the 
enzymatic digestion can be stopped. The microscopic 
evaluation of the degradation requires experience with 
ad-MVF isolation and is based on a qualitative 
assessment of the cell-vessel suspension (Figure 2). 
Figure 2. Isolation of ad-MVF. 
Microscopic image of a cell-vessel 
suspension during the ad-MVF isolation 
process. The enzymatic digestion should 
be stopped when the smear contains 
large (arrow), medium-sized and small 
(arrowheads) ad-MVF as well as single 
cells. Overdigestion with collagenase 
results in a single cell suspension 
without ad-MVF. Scale bar = 50 µm. 
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Too long exposition to collagenase results in ad-MVF destruction. Hence, the enzymatic 
digestion should not exceed 10 min. In the subsequent filtration and centrifugation steps, not 
all single cells are removed from the ad-MVF solution. Importantly, the fragments exhibit a 
markedly lower vascularization capacity after complete purification. This finding may be 
explained by the speculation that a "physiological environment" is critical for the 
vascularization potential of ad-MVF. ad-MVF contain a relevant fraction of mesenchymal 
stem cells, which are closely attached to their physiological niche to the fragments 
[MCDANIEL et al., 2014]. Hence, the ad-MVF isolation process should be as minimally 
invasive as possible to preserve the microvascular biology of the fragments.  
 
One major advantage of ad-MVF isolation is the short enzymatic digestion time of only ~ 10 
min. In contrast, freshly isolated single-cell isolates, such as the SVF, commonly require 
enzymatic digestion times of 60 - 90 min [CHEN et al., 2016; SPÄTER et al., 2018]. 
Consequently, ad-MVF may be particularly suited for intraoperative one-step isolation and re-
implantation procedures. However, to achieve this goal, their isolation will have to be 
facilitated by automated closed-system devices, which are already available for the 
preparation of stem cells, SVF or platelet-rich plasma in different fields of surgery 
[DONNENBERG et al., 2011; COHN et al., 2015; TISSIANI and ALONSO, 2016; ZIMMERMANN et 
al., 2017].  
 
6.1.2 Animal Models 
6.1.2.1 Modified Dorsal Skinfold Chamber Model 
The dorsal skinfold chamber model is a versatile tool, originally introduced for repetitive 
intravital microcirculatory analyses in hamsters 
[ENDRICH et al., 1980]. During the preparation, one 
layer of skin and subcutis including the panniculus 
carnosus muscle is completely removed within the 
circular area of the chamber's observation window 
[MENGER et al., 2002]. Subsequently, the frames of 
the chamber are fixed with connecting screws with a 
frame-to-frame distance of 400 - 500 µm using 
stainless steel nuts as spacers to prevent 
compression of the supplying arterioles and the 
draining venules of the chamber tissue [LASCHKE et 
al., 2011]. Finally, the chamber window is 
hermetically closed with a cover glass providing 
Figure 3. Dorsal skinfold chamber. 
C57BL/6 mouse mounted with a dorsal 
skinfold chamber. The titanium chamber 
minimally affects animal behavior, such as 
feeding, ambulating or body hygiene. Note 
the slight tilting of the chamber to the right 
side. Chamber weight = ~ 2 g. Scale bar = 
25 mm. 
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access for microscopy. The chamber is well tolerated by rodents (Figure 3). However, the 
traditional preparation does not allow microcircular analyses of the surrounding skin.  
 
SORG et al. [2007 and 2009] modified the dorsal skinfold chamber by creating a small circular 
defect with preserved surrounding skin for wound healing studies. This modified dorsal 
skinfold chamber was herein used for the implantation of prevascularized and non-seeded 
single layer Integra matrices for repetitive intravital fluorescence microscopic and planimetric 
analyses. Even though the surgical dissection is easy to learn and requires no more than 30 
min once mastered, the model exhibits a few technical and biological pitfalls: 
• Loss of elasticity of the dorsal skinfold. This phenomenon may compromise the 
experiments twofold. First, the chamber is prone to tilting (see also Figure 3), which 
finally jeopardizes the vascularization within the observation window. Second, the 
tissue within the chamber tends to vertical sliding during the 14-days observation 
period, particularly if the skin is sutured too tightly to the cranial chamber, which might 
result in skin necrosis with loss of fixation (Figures 4A-C). To prevent this 
complication, the chamber has to be mounted precisely in the midline of the dorsal 
skin (i.e., the skinfold) and the skin should be fixed with sufficient tissue and adequate 
sutures without excessive pressure.  
• Inadequate defect preparation. It is crucial to dissect exactly 4 mm-sized defects 
because too large defects technically compromise the experiments in two ways. First, 
Figure 4. Technical pitfalls of the modified dorsal skinfold chamber. Epi-illumination (A-C) and trans-
illumination (D-F) stereomicroscopic images of a non-seeded single layer Integra (A, asterisk) immediately 
after implantation (A and D), at day 6 (B and E) as well as at the end of the 14-days observation period (C 
and F). Note the vertical sliding within the observation window throughout the course of the experiment (A 
and C, arrowheads). In non-seeded implants, transected subcutaneous vessels are only associated with 
minor implant-induced hemorrhages (D, arrhowheads). Scale bars = 2 mm. 
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the implanted skin substitute may not appropriately inosculate to the surrounding skin 
following hematoma or seroma formation between the wound edges and the implant. 
Second, the ingrowing epithelium may not cover the implanted Integra and, in rare 
cases, even result in an epithelial barrier between the wound bed and the implant. 
This problem was herein eliminated by careful microsurgical dissection of the circular 
defect. For a precise match of defect and implant size, sterile dermal punches were 
used. However, the defects should not be created using the punches alone because 
the mechanical trauma of punching may again compromise the vascularization of the 














• Epithelial coverage and microcirculatory analysis. The main advantage of wound 
healing studies in the dorsal skinfold chamber is the possibility of intravital 
fluorescence microscopy. The analysis of the microcirculation requires an undisturbed 
access to the surface of the implant. In implants with increased vascularization, the 
epithelial coverage is significantly enhanced. Hence, the centripetally growing 
epithelium may interfere with microcirculatory analyses (Figure 5). With the present 
experimental design it was possible to image the microvasculature without restrictions 
Figure 5. Biological pitfalls of the modified dorsal skinfold 
chamber. Epi-illumination (A and B) and trans-illumination (C and D) 
stereomicroscopic images of an ad-MVF-seeded single layer Integra 
immediately after implantation (A and C) and at the end of the 14-
days observation period (B and D). B and D: Increased implant 
vascularization is associated with enhanced epithelial coverage, 
interfering with microcirculatory analyses. Epithelial layer = area 
between dashed black and white line in B. Note large (D, 
arrowheads) and smaller (D, arrow) vessels feeding the ad-MVF-
derived microvascular network 14 days after implantation. Scale bars 
= 2 mm. 
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at day 0, 3, 6 and 10 after implantation. However, at day 14, intravital fluorescence 
microscopy was clearly limited in prevascularized matrices, which were mainly 
covered with an epithelial layer at this time point. A possible solution would be the 
dissection of bigger defects for future experiments. 
• Implant-induced bleeding and microcirculatory analysis. The preparation of full-
thickness skin defects includes the transection of large-caliber subcutaneous vessels. 
Excessive bleeding was encountered in the transection area of such vessels. 
However, in the majority of the experiments, only marginal hemorrhages were present 
in the contact zone of transected vessels and the implanted Integra (Figure 4D). 
Prevascularized Integra exhibits a higher risk for significant bleeding, which may 
jeopardize microcirculatory analyses. The highest risk for relevant hemorrhages was 
found at day 3 and 6 after implantation, i.e. immediately after inosculation to the host 
microvasculature. For the quantification of implant-induced hemorrhages, a semi-
quantitative hemorrhagic score was introduced in subsequent studies [SPÄTER et al., 
2017].  
• Age of experimental animals. Microcirculatory analyses with the dorsal skinfold 
chamber are usually performed in mice exhibiting a body weight of 22 - 25 g. For the 
herein presented wound healing experiments, however, C57BL/6 mice with a body 
weight of 25 - 28 g are recommended. This detail may be important because 
significant difficulties were experienced using younger mice. Remarkably, after the 
preparation of full-thickness skin defects in young animals, it was not possible to 
implant Integra without a step-off to the surrounding skin. This subtle incongruence 
results in a delayed or absent epithelial coverage of the implants and is among the 
main biases of epithelialization studies using the dorsal skinfold chamber model. One 
reason could be a thinner skin or a thinner subcutaneous / muscular layer in younger 
animals. 
• Skin pigmentation of experimental animals. C57BL/6 mice can exhibit large 
pigmented areas on their skin [CURTIS et al., 2011]. These "black dots" impair the 
quality of the intravital fluorescence microscopic analysis of the skin's 
microvasculature. Unfortunately, pigmentation is neither predictable nor visible 
through the black fur of the mice. Consequently, the back of the animals was 
depilated before anesthetizing them and pigmented animals were excluded from 
further experiments.  
• Excision of tissue specimens for in vitro analyses. After the in vivo observation period, 
the Integra implants were excised for histological and immunohistochemical 
assessment. A common mistake is the interruption of the implant/epithelium interface 
by careless manipulation of the specimens. This can be avoided by excising the 
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specimens "en block", i.e. as a rectangular full-thickness excision including both the 
implant and the contralateral skinfold with a safety margin of at least 10 mm on each 
side of the implant. For further enhancement of the specimens, the animals can be 
bled out before killing them. This reduces the harvesting-associated bleeding with 
lower contamination of the specimens with erythrocytes before fixation.  
Rodent wound healing experiments are often compromised by contraction of the panniculus 
carnosus muscle [DUNN et al., 2013; GRIFFIN et al., 2015]. This problem is mainly avoided in 
the dorsal skinfold chamber model by fixation of the skin between the two titanium frames. 
Moreover, the implants are protected from exsiccation and manipulation by the animal in the 
closed chamber [MICHAEL et al., 2013]. Consequently, it is not necessary to regularly change 
wound dressings, which may influence the healing process. In summary, the modified dorsal 
skinfold chamber is an extremely versatile tool for the study of vascularization and 
epithelialization of dermal skin substitutes in murine full-thickness skin defects. It represents 
a quick and cost-effective experimental approach and allows dynamic insights into the 
microvascular pathophysiology of healing wounds.  
6.1.2.2 Autologous Skin Graft Model 
In clinical skin reconstruction, Integra is commonly used in a staged procedure with STSG 
coverage after revascularization of the dermal skin substitute. To address this fact, a novel 
mouse wound model was developed in the present thesis for a proof-of-concept study using 
ad-MVF-prevascularized bilayer Integra. For this purpose, two established mouse models 
were combined: The head punch model, which has been widely used for wound healing 
studies [KIM et al., 2001; REID et al., 2004] and a model described by SCHENCK et al. [2014], 
who used a subcutaneous titanized mesh to prevent wound contraction after Integra 
implantation on the back of mice. In the initial stage of this experiment, bilayer Integra was 
implanted into 8 mm-sized full-thickness skin defects on the skull of CD1 nu/nu mice without 
additional fixation. However, after a few days, the implants were lost due to loosening. This 
problem was solved by placing a titanized mesh underneath the implants directly on the bone 
and slightly overlapping the wound edges. Technically, the mesh is not fixed on the bone, but 
it is critical that the securing sutures incorporate the skin, the Integra as well as the titanized 
mesh. The bilayer Integra is well protected against exsiccation and additional bandages on 
the wounds were not necessary. The animals tolerated the implants well and showed normal 
behavior throughout the 21 days of the experiment. However, the construct is not entirely 
resistant against external manipulation and the animals should be housed alone and without 
litter, which significantly contaminates the implanted Integra. In contrast to the dorsal skinfold 
chamber, in vivo analyses of the implants' vascularization are challenging using the skull 
model. Photo-acoustic imaging was herein established for the assessment of tissue 
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oxygenation within implanted Integra. The results of this analysis were used as a surrogate 
parameter for the vascularization of the dermal skin substitutes. For a reliable and 
reproducible investigation, the anesthetized mice needed to be kept warm and carefully 
fixed. 
In the second part of this study, STSG coverage was performed 10 days after the 
implantation of prevascularized and non-seeded Integra. In the pertinent literature, the 
harvest of STSG in mice is thought to be extremely difficult due to the loose and thin skin of 
the animals. Accordingly, murine investigations on skin transplants were commonly 
performed using full-thickness skin grafts [LINDENBLATT et al., 2008 and 2010]. In the 
present thesis, a simple technique is introduced that allows the harvest of STSG in mice.  
For this purpose, full-thickness skin grafts are excised from the groin of anesthetized CD1 
nu/nu mice. The skin grafts are secured with needles on a sterile cork plate (Figure 6A). 
Next, the adjacent adipose tissue and the deep dermal layer including a rich vascular 
plexus is microsurgically removed using a stereomicroscope (Figure 6B). In the meantime, 
the groin wounds are closed with interrupted sutures and the silicone pseudoepidermis of 
the bilayer Integra is carefully removed after surgical disinfection (Figure 6C). Finally, the 
STSG is secured with interrupted sutures and an additional titanized mesh, as described by 
FRUEH et al. [2018b]. Overall, the procedure is technically feasible and, once mastered, can 
be performed within 30 min. As indicated by histology, the skin grafts harvested using this 
technique exhibit typical STSG configuration. One critical step of this operation is the 
adequate positioning of the 8 mm-sized defects on the small skull of the mice. It should be 
placed exactly on the midline with a distance to the eyelids of ≥ 3 mm (Figure 6D). If the 
wound-eyelid distance is too small, the tension of the suture may lead to incomplete lid 
closure with subsequent ocular complications. After transplantation the STSG are easily 
accessible for stereomicroscopic imaging, allowing the planimetric quantification of STSG 
survival at the end of the experiments.  
 
The CD1 nu/nu mice used for this experiment exhibit advantages for the investigation of 
prevascularized dermal skin substitutes. First, they are hairless, which facilitates repetitive 
Figure 6. Skin graft model. A Full-thickness skin graft after excision from the groin of a CD1 nu/nu mouse. B 
Microsurgical defatting and removal of the deep dermis (asterisk) to harvest a STSG (arrow). C Removal of the 
silicone pseudoepidermis (asterisk) 10 days after bilayer Integra (arrowhead) implantation on the skull of a CD1 
nu/nu mouse. D STSG in situ. Scale bars: A, C and D = 4 mm, B = 2.5 mm. 
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intravital stereomicroscopic and photo-acoustic imaging. Particularly for photo-acoustic 
imaging, the thick and often pigmented skin of C57BL/6 mice has been shown to prevent a 
reliable quantification of tissue oxygenation. Second, the immunoincompetent recipient 
strain allows the transplantation of GFP+ ad-MVF harvested from transgenic C57BL/6 mice 
without inducing a rejection reaction. On the other hand, it has to be considered that CD1 
nu/nu mice lack a thymus and, thus, are unable to produce T-cells. This may give rise to 
concerns about their eligibility to study implanted biomaterials and, in particular, wound 
healing, because inflammatory processes are essentially involved in the regulation of 
vascularization and lymphangiogenesis. In fact, epidermal and dermal T-cells are critically 
involved in the regulation of wound healing in mice by local production of growth factors and 
inflammatory cytokines [JAMESON et al., 2002; KEYES et al., 2016; HAERTEL et al., 2018]. 
This limitation should be taken into account when planning and executing wound healing 
experiments with this immunoincompetent animal strain. In conclusion, the herein 
introduced autologous skin graft model is a promising and minimally invasive tool to 
analyze the fate of STSG in mice. 
 
6.2 Discussion of Results 
6.2.1 Characterization of ad-MVF 
One prerequisite for the successful prevascularization of Integra using ad-MVF is a 
penetration of the seeded fragments into the dermal skin substitute's pores. This may 
crucially depend from the size of individual ad-MVF. Therefore, in the first study of this thesis, 
the length distribution of freshly isolated ad-MVF was assessed by means of microscopic 
analyses. The mean length of isolated ad-MVF was 42 ± 1 µm with the majority of ad-MVF 
sized between 20 - 80 µm. Integra exhibits pore sizes between 20 - 125 µm and immediately 
after the seeding process, only a few ad-MVF were found in the inner structure of the 
matrices. However, 14 and 21 days following implantation into full-thickness skin defects, 
GFP+ ad-MVF were homogeneously distributed within the Integra implants, indicating a fast 
ingrowth of the ad-MVF-derived microvascular network. Moreover, microscopic analyses 
revealed that ad-MVF retain their mature microvascular morphology with hierarchical 
microvessel segments. It was further shown that ad-MVF include arterioles, capillaries and 
venules, as indicated by immunohistochemical staining of the endothelial cell marker CD31 
and the perivascular cell marker α-SMA. To assess the cellular composition of freshly 
isolated ad-MVF, additional flow cytometric analyses were performed. They showed that ad-
MVF contain 26 ± 2 % CD31+ endothelial cells, 17 ± 2 % α-SMA+ perivascular cells as well 
as 9 ± 1 % cells positive for the mesenchymal stem cell marker CD117. In conclusion, these 
findings indicate that the isolation process of ad-MVF does not significantly impair their 
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microvessel morphology. This may be the main reason for an intriguing vascularization 
capacity, which is markedly higher when compared to the adipose tissue-derived SVF under 
comparable conditions [SPÄTER et al., 2018]. 
6.2.2 Vascularization of Integra 
In the present thesis, ad-MVF are introduced as a novel prevascularization strategy for the 
dermal skin substitute Integra. A fast revascularization is the key challenge for engineered 
tissues. Therefore, the vascularization of Integra was analyzed using different experimental 
approaches.  
Repetitive intravital fluorescence microscopy was performed at day 0, 3, 6, 10 and 14 after 
implantation of prevascularized and non-seeded single layer Integra into the dorsal skinfold 
chamber. Importantly, this technique allowed assessing the angiogenic activation of the host 
microvasculature as well as the formation and maturation of ad-MVF-derived microvessels. 
Three days after the implantation of non-seeded Integra, the host microvasculature showed 
angiogenic budding and capillary widening towards the implant (Figure 7A). However, 
throughout the course of the 14-days experiment, significant implant vascularization was not 
observed, as indicated by a low functional microvessel density and only a few blood-perfused 
regions of interest. In contrast, ad-MVF-seeded Integra revealed onset of blood perfusion as 
early as 6 days after implantation. Fluorescence microscopy allowed documenting the 
inosculation of ad-MVF-derived immature microvessels with ingrowing microvessels from the 
surrounding host skin (Figure 7B). This finding is important and proofs that the ad-MVF-
induced microvascular network is functional and able to provide the center of the implants 
with oxygen. Moreover, it supports the generally accepted theory that skin substitutes are 
primarily revascularized through internal inosculation, i.e. the ingrowth of host microvessels 
[LASCHKE et al., 2009; FRUEH et al., 2018a]. Even though a few implants exhibited 
inosculation already at day 3, it was not possible to objectify blood flow within these implants 
at that time point. Hence, it may be speculated that the formation of the ad-MVF-derived 
Figure 7. Intravital fluorescence microscopy A Non-seeded single layer Integra 6 days after implantation with 
host microvessels (arrows) and angiogenic budding (arrowheads) towards the implant's border. B ad-MVF-
seeded Integra 6 days after implantation with ingrowing host microvessels (arrowheads), which inosculate with 
the ad-MVF-derived microvessels (arrow). Note the large diameter of the immature ad-MVF-derived 
microvasculature. C Hierarchical microvascular network 10 days after implantation of an ad-MVF-seeded Integra. 
Arrowheads = blood-perfused microvessels. Blue light epi-illumination intravital microscopy with 5 % FITC-
labeled dextran. Dashed lines = implant border. Scale bars: A and B = 120 µm, C = 60 µm. 
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microvascular network requires at least 72 hours. Indeed, implants with inosculation at day 3 
showed a tendency to more severe bleeding, which may be due to the premature 
microvascular network. After inosculation, the implants' vascularization rapidly increased and 
~ 80 % blood-perfused regions of interest were already found at day 10 with a functional 
microvessel density of > 80 cm/cm2. In line with these findings, the maturation of the ad-
MVF-derived microvasculature was associated with decreasing microvessel diameters and 
an increase of the centerline red blood cell velocity over time. Moreover, it was possible to 
visualize the development of a highly hierarchical microvascular network, as indicated by 
fluorescence microscopy 10 days after implantation (Figure 7C).  
Histological and immunohistochemical analyses of Integra implants at day 14 confirmed the 
intravital microscopic findings. The collagen-glycosaminoglycan matrix of ad-MVF seeded 
Integra was homogeneously filled with a well-vascularized granulation tissue whereas non-
seeded implants were only invaded by single cells. Accordingly, a > 3 times higher density of 
CD31+ microvessels was found in prevascularized implants. Importantly, > 95 % of these 
microvessels stained positive for GFP, hence originated from the ad-MVF. Suprisingly, 47 ± 9 
% GFP+/CD31+ microvessels were also detected in the skin surrounding the implants. This is 
remarkable and indicates that the ad-MVF-derived microvasculature not only vascularized 
the Integra but also invaded the surrounding skin. Consequently, it may be assumed that ad-
MVF-seeded Integra is additionally revascularized by external inosculation, i.e. the 
connection of outgrowing microvessels with the host microvasculature. The reason for the 
high growth activity of transplanted ad-MVF remains elusive. One possible explanation could 
be a strong hypoxic stimulation prior to inosculation with subsequent angiogenic growth 
factor expression.  
The aim of the second in vivo experiment was to confirm the promising results of the dorsal 
skinfold chamber in an experimental model closer to human translation. For this purpose, ad-
MVF-seeded and non-seeded double layer Integra were implanted in bradytrophic full-
thickness skin defects on the skull of CD1 nu/nu mice for 21 days. The vascularization of the 
implants was assessed by means of photo-acoustic imaging, trans-illumination 
stereomicroscopy and immunohistochemistry. Photo-acoustic imaging revealed a ~ 4 times 
higher oxygen saturation of prevascularized Integra compared with non-seeded implants. 
Accordingly, trans-illumination stereomicroscopy showed a markedly higher vascularized 
area in prevascularized Integra. Finally, immunohistochemical analyses confirmed markedly 
higher microvessel densities in ad-MVF-seeded implants when compared to controls. Again, 
> 95 % of the microvessels within the implants were GFP+, i.e. originated from the 
transplanted ad-MVF, most probably because in the skull model the surrounding skin 
represents the only site for inosculation with the host microvasculature. Moreover, the 
defects were markedly bigger (8 mm). Furthermore, the double layer Integra was used. 
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Hence, the ad-MVF had to be seeded on the bottom side of the matrices and were implanted 
in direct contact with the bradytrophic bone of the mouse skull. The findings of this study 
should be understood as further evidence that ad-MVF survive in an initially hypoxic 
environment and rapidly reassemble into a microvascular network even when seeded on the 
bottom side of implanted Integra. This is especially noteworthy, because in the clinical setting 
the commonly used double layer Integra would also have to be seeded on the "bottom" of the 
implant. 
In conclusion, the analyses of both mouse models indicate that ad-MVF-seeding is a highly 
effective strategy to prevascularize Integra, leading to a functional microvascular network 
within ~ 10 days after implantation of the dermal skin substitute. 
 
6.2.3 Integration and Epithelialization of Integra 
A stable reconstruction of skin defects crucially depends on the integration of a dermal skin 
substitute. The collagen content of skin substitutes is an accepted parameter for tissue 
integration. Therefore, the total collagen content of implanted single layer Integra was herein 
quantified using Sirius red staining and polarized light microscopy. Due to birefringence, 
mature type I collagen fibers exhibit a reddish color under polarized light [JUNQUEIRA et al., 
1979]. The collagen fiber density was evaluated in relation to the adjacent healthy skin. In 
line with the improved vascularization, ad-MVF-seeded Integra exhibited markedly higher 
amounts of collagen fibers when compared to non-seeded controls. However, the 
prevascularized implants only showed a low density of type I collagen in comparison to 
normal skin. These results are comparable to analyses of ADSC-seeded Integra in a rat 
model [MERUANE et al., 2012]. Obviously, and despite ad-MVF-enhanced vascularization, the 
loose collagen-glycosaminoglycan matrix of the dermal skin substitute may not provide 
sufficient stability after 14 - 21 days. Consequently, the neodermis is still remarkably fragile 
and should be protected from excessive mechanical stress.  
Beside integration, the restoration of the epithelial barrier is critical for the outcome of 
reconstructed skin. In previous rodent experiments, increased vascularization of the dermal 
support enhanced wound re-epithelialization by in situ delivery of epidermal keratinocytes 
[LUGO et al., 2011]. Hence, a faster epithelialization of the ad-MVF-seeded Integra implants 
was expected in the present study. In fact, repetitive planimetric measurements of the 
epithelialized implant surface area revealed a significantly higher epithelialization of the 
prevascularized Integra at day 10 and 14. Because planimetry of the thin epithelial coverage 
is prone to inter-observer variability, additional immunohistochemical analyses were 
performed after the in vivo experiment. The cytokeratin+ multi-layered epithelium covered 58 
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± 7 % of the diameter of ad-MVF-seeded Integra, which was significantly greater compared 
with 36 ± 5 % in the control group. Interestingly, the results of the immunohistochemical 
analyses were comparable to the planimetric assessment, indicating an acceptable accuracy 
of the latter. Taken together, it was hereby shown that 4 mm-sized defects, even though 
rather small for wound healing studies in mice, are appropriate for the evaluation of epithelial 
regeneration in the dorsal skinfold chamber and throughout an observation period of 14 
days. 
 
6.2.4 Early Skin Grafting of Integra 
For final testing of the ad-MVF-based prevascularization strategy, STSG coverage of ad-
MVF-seeded and non-seeded bilayer Integra was performed 10 days after implantation into 
full-thickness skin defects on the skull of CD1 nu/nu mice. The successful transplantation of 
skin grafts requires an intact microvascular network at the recipient site, supplying the 
avascular skin with oxygen. It is therefore not surprising that pilot experiments with one-
staged Integra implantation and STSG coverage resulted in complete graft necrosis. Based 
on the previous experiments in the dorsal skinfold chamber model and on histological 
analyses of the prevascularized matrices, it was hypothesized that the vascularization as well 
as the integration of the neodermis should allow STSG coverage ~ 10 days after implantation 
of prevascularized Integra. Indeed, STSG coverage of ad-MVF-seeded Integra at this time 
point resulted in a survival rate of 40 ± 11 %, as indicated by planimetric analyses. In 
contrast, skin grafting of non-seeded implants was associated with a statistically significantly 
lower survival rate of 5 ± 5 %. Moreover, STSG on prevascularized Integra mainly exhibited 
an intact epidermal and dermal structure, whereas skin grafts on non-seeded implants were 
histopathologically characterized by tissue necrosis. Remarkably, the surviving STSG were 
primarily revascularized in the center of the implants. Moreover, the necrotic area was 
located in the grafts' periphery in all specimens. This finding is coherent with the pertinent 
literature on skin graft revascularization [O'CEALLAIGH et al., 2006; CAPLA et al., 2009; 
LINDENBLATT et al., 2010]. However, these previous experiments were performed without 
dermal skin substitutes and the authors speculated that central graft revascularization may 
be due to a i) faster ingrowth of host microvessels from the wound bed "underneath" the skin 
graft and ii) higher expression of angiogenic growth factors in the central area of the grafts, 
where oxygen is scarcely delivered through diffusion. Importantly, in the present wound 
model with ad-MVF-derived microvascular networks, the first argument may not hold true, 
because the newly forming microvessels may have exhibited less inosculation potential when 
compared to physiological vessels. This, however, might have even aggravated the hypoxic 
stress and subsequent growth factor expression within the center of the STSG. 
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Consequently, after inosculation to the surrounding host microvasculature, the angiogenic 
activity within the grafts may have been particularly high in the hypoxic center. This 
speculation is supported by the fact that only single GFP+ cells integrated in STSG 
microvessels were found but no entirely GFP+ vascular structures. Hence, the 
prevascularized Integra might have rather provided the STSG with oxygen through diffusion 
than through early inosculation. Taken together, it was possible to show that the 
prevascularization of Integra using ad-MVF allows STSG coverage as early as 10 days after 
implantation onto bradytrophic scalp defects in mice. 
 
6.2.5 ad-MVF and Lymphangiogenesis 
The lymphatic system is critically involved in the regulation of fundamental biological 
processes, such as the immune response and immunomodulation, the intestinal absorption 
of lipids and the maintenance of tissue fluid homeostasis [ALITALO et al., 2005; CUENI and 
DETMAR, 2008; ROCKSON, 2010]. Thin-walled capillaries represent the smallest unit of the 
cutaneous lymphatic system, which drains protein-rich lymph fluid from the extra-cellular 
spaces of the skin [HIRAKAWA and DETMAR, 2004]. Even though the cutaneous lymphatic and 
blood vascular systems are intimately related in terms of embryology and anatomy, the role 
of lymphangiogenesis for wound healing has been neglected for decades, mainly due to a 
lack of sophisticated lymphatic imaging techniques as well as lymph-specific histological 
markers [FRUEH et al., 2018a]. This is remarkable, because PAAVONEN et al. [2000] 
demonstrated almost 20 years ago that lymphangiogenesis, i.e. the growth of new lymphatic 
vessels, is an integral part of wound healing. Furthermore, subsequent experimental studies 
revealed that lymphangiogenic growth factor treatment enhances lymphatic regeneration 
across incisional wounds [SAARISTO et al., 2004] as well as in diabetic wounds [SAARISTO et 
al., 2006]. The consequence of these findings is the incorporation of the lymphatic system 
into artificial skin. Indeed, engineered skin substitutes including both blood and lymphatic 
vessels have recently been introduced [MARINO et al., 2014; KLAR et al., 2014; MATSUSAKI et 
al., 2015]. For this purpose, the lymphatic vasculature was engineered by co-culturing 
angiogenic cells, such as HDMEC or human umbilical vein endothelial cells, with fibroblasts 
and keratinocytes. Based on these results, it was hypothesized in the present thesis that ad-
MVF-prevascularization may also stimulate the formation of a lymphatic vascular network 
within implanted Integra.   
 
For the quantification of lymphangiogenesis in the dorsal skinfold chamber experiment, 
lymphatic vessel endothelial hyaluronan receptor (LYVE)-1+ lymphatic vessels were detected 
in the implants and the surrounding skin by means of immunohistochemistry. Importantly, 
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both prevascularized and non-seeded Integra contained lymphatic vessels at day 14 after 
implantation. However, ad-MVF-seeded Integra exhibited a significantly higher lymphatic 
vessel density (21 ± 6 mm-2) compared with control implants (2 ± 1 mm-2).  
 
It was further shown that 68 % of the lymphatic vasculature in prevascularized Integra was 
GFP+, hence originated from the transplanted ad-MVF (Figure 8A-C). In contrast, only 10 % 
of the lymphatic vessels in the surrounding skin exhibited a GFP+ endothelium. Remarkably, 
the GFP+ lymphatic vessels invading the host skin tissue were mainly localized close to GFP- 
lymphatic vessels (Figure 8D-F). However, it was not possible to identify lympho-lymphatic 
anastomoses by means of immunohistochemistry. Nonetheless, it can be assumed that the 
outgrowing ad-MVF-derived lymphatic vessels connected to the lymphatic system of the 
host. The analysis of lymphangiogenesis in the skin graft model revealed similar results. ad-
MVF-seeded bilayer Integra exhibited significantly more lymphatic vessels when compared 
to non-seeded control implants. In this study, an even higher percentage of GFP+ lymphatic 
vessels was found in prevascularized implants (88 ± 1 %). Additional analyses were 
performed for the detection of LYVE-1+/GFP+ lymphatic vessels in the STSG 5 days after 
implantation onto prevascularized and non-seeded Integra. Even though a few LYVE-
1+/GFP+ single cells were found within the STSG, these cells were not integrated into the 
endothelium of the skin grafts' lymphatic vasculature. This finding may be explained by the 
fact that lymphangiogenesis is a slower biological process when compared to angiogenesis 
Figure 8. ad-MVF-derived lymphatic vascular network. Immunohistochemical detection of LYVE-1+ lymphatic 
vessels in ad-MVF-seeded bilayer Integra (A-C) and surrounding skin (D-F) 14 days after implantation into the 
dorsal skinfold chamber of a C57BL/6 mouse. A-C ad-MVF-derived LYVE-1+/GFP+ lymphatic vessels 
(arrowheads) and LYVE-/GFP+ blood vessel (B and C, arrow) in prevascularized Integra. Dashed line = 
skin/Integra border. D-F ad-MVF-derived LYVE-1+/GFP+ lymphatic vessel (arrowhead) invading the surrounding 
skin. Note the LYVE-1+/GFP- host lymphatic vessel (D and F empty arrowhead) in close vicinity to the ad-MV-
derived lymphatic vessel. Scale bars = 50 µm. 
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and lympho-lymphatic anastomoses are only expected > 10 days after implantation into skin 
defects [MARINO et al., 2014].  
 
These results represent the first sophisticated assessment of the lymphatic vasculature in 
Integra and probably are the most interesting finding of this thesis. The fact that ad-MVF are 
not only intriguing vascularization units but also promote lymphatic regeneration should be 
discussed in detail. As indicated by flow cytometric analyses, ad-MVF contain ~ 30 % 
endothelial cells. The epididymal fat pads also contain lymphatic vessels and, therefore, ad-
MVF may also be characterized by a significant fraction of lymphatic vessel fragments and 
lymphatic endothelial cells. In analogy to blood vessel fragments, these lymphatic vessel 
fragments may rapidly reconnect with each other after transplantation and contribute to the 
formation of an ad-MVF-derived lymphatic network. Moreover, it may be speculated that the 
fragment-associated mesenchymal stem cell fraction is capable of differentiating into 
lymphatic endothelial cells and contributes to lymphatic vessel formation after 
transplantation. According to this assumption, ADSC have shown potential to promote 
lymphangiogenesis both in vitro [STRASSBURG et al., 2016] and in vivo [YAN et al., 2011]. 
Taken together, ad-MVF not only exhibit a high angiogenic activity but also represent exciting 
building blocks for the restoration of the lymphatic system. Based on the findings of the 
present thesis, novel experiments investigating the value of ad-MVF transplantation in 




In the present thesis, ad-MVF-seeding has been introduced as a novel and promising 
prevascularization strategy for the dermal skin substitute Integra. The microvascular 
fragments enhance the vascularization and lymphangiogenesis of Integra and also result in a 
faster integration and epithelialization of the implant. This prevascularization strategy might 
also be suitable to enhance the performance of other engineered skin substitutes. Key 
advantages of ad-MVF prevascularization are the short isolation time of the microvascular 
fragments and their intact microvascular characteristics, which are prerequisites for an 
intraoperative one-staged application. However, the isolation process will have to be 
markedly facilitated by means of automate closed-system devices. Moreover, it has to be 
proven that ad-MVF harvested from subcutaneous adipose tissue of humans exhibit an 
equally high vascularization capacity compared with murine ad-MVF. If these hurdles are 
mastered, ad-MVF may soon be taken from bench to bedside. From the clinician's 
perspective, they are indeed a promising strategy to enhance the vascularization and 
lymphangiogenesis of engineered tissue substitutes. 
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